acebutolol and Anemia, Iron-Deficiency

acebutolol has been researched along with Anemia, Iron-Deficiency in 294 studies

Research

Studies (294)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (3.74)	29.6817
2010's	182 (61.90)	24.3611
2020's	101 (34.35)	2.80

Authors

Authors	Studies
Bielesz, B; Gabriel, M; Gleiss, A; Hörl, WH; Lorenz, M; Monteforte, R; Prikoszovich, T; Sunder-Plassmann, G; Wolzt, M	1
Anker, SD; Becher, PM; Benson, L; Corovic Cabrera, C; Dahlström, U; Fudim, M; Jankowska, EA; Lund, LH; Rosano, GMC; Savarese, G; Schrage, B	1
Connolly, M; Lim, CK; Mirkazemi, C	1
Baldus, S; Dumitrescu, D; Gerhardt, F; Hellmich, M; Kramer, T; Natsina, K; Rosenkranz, S; Ten Freyhaus, H; Viethen, T; Wissmüller, M	1
Donato, AA; Green, J	1
Bayés-Genís, A; Miñana, G; Núñez, J	1
Bisbe, E; Carol-Boeris, F; García-Erce, JA; Laso-Morales, MJ; Martínez-López, F; Muñoz, M; Pontes-García, C; Vives, R	1
Aronico, N; Barteselli, C; Bergamaschi, G; Bonadeo, E; Del Rio, V; Di Sabatino, A; Gabba, M; Gentile, L; Livraghi, A; Mengoli, C; Perotti, C	1
Ataíde, R; Biselele, K; Braat, S; Chinkhumba, J; Harding, R; Larson, L; Moya, E; Mwangi, MN; Mzembe, G; Pasricha, SR; Phiri, KS; Robberstad, B; Rogerson, S; Simpson, J; Stones, W	1
Schaefer, B; Wolf, M; Zoller, H	1
Casà, A; Crispino, F; Grova, M; Macaluso, FS; Maida, M; Mannino, M; Orlando, A; Renna, S; Rizzuto, G	1
Maniar, AR; Maniar, RN; Mishra, A; Sanghavi, N	1
Arjona Berral, JE; Baquero Úbeda, JL; Casellas Caro, M; Cerezales, M; Cuervo, J; García-Erce, JA; Gredilla Díaz, E; Hidalgo, MJC; Jiménez Merino, S; Martín Bayón, I; Muñoz Solano, A; Nicolás Picó, J; Ruano Encinar, M; Torras Boatella, MG	1
Admetlló, M; Alvarado, M; Barreiro, E; Duran-Jordà, X; Echeverría-Esnal, D; Gea, J; Martín-Ontiyuelo, C; Rodó-Pin, A; Rodríguez-Chiaradía, DA	1
Anker, SD; Butler, J; Coats, AJS; Comin-Colet, J; Dorigotti, F; Fabien, V; Filippatos, GS; Friede, T; Goehring, UM; Jankowska, EA; Khan, MS; Metra, M; Piña, IL; Ponikowski, P; Rosano, G; Van Veldhuisen, DJ	1
Carlin, K; Fukasawa, S; Horslen, SP; Kaenkumchorn, TK; Rosete, BE; Wendel, D	1
Altuntaş, F; Bozan, E; Çakar, MK; Candır, BA; Dal, MS; İskender, D; Seçilmiş, S; Ulu, BU; Yaman, S; Yiğenoğlu, TN	1
Bayés-Genís, A; Cardells, I; de la Espriella, R; Górriz, JL; Lorenzo, M; Núñez, J	1
Chen, J; Chen, Y; Jin, L; Liu, Q; Luo, S; Mei, Z	1
Fuyuno, Y; Harada, A; Matsuno, Y; Morisaki, S; Saiki, T; Suekane, H; Suzuki, T; Taniguchi, Y; Torisu, T; Umeno, J	1
Kato, J; Kawabata, H; Takahashi, T; Tamai, S; Tamura, T	1
Anker, SD; Butler, J; Dorigotti, F; Fabien, V; Filippatos, G; Jankowska, EA; Kirwan, BA; Macdougall, IC; Metra, M; Pagnesi, M; Ponikowski, P; Rosano, G; Ruschitzka, F; Tomasoni, D; van der Meer, P	1
Ahmed, FZ; Kalra, PA; Kalra, PR; Pollock, RF	1
Ausseil, J; Feugeas, JP; Guieu, R; Manceau, H; Masson, D; Peoc'h, K; Puy, H; Sablonniere, B	1
Aboustate, N; Church, R; Dekker, GA; Froessler, B; Hodyl, NA; Kelly, TL; Palm, P; Schubert, KO	1
Aksan, A; Anand, S; Stein, J; Zepp, F	1
Cushway, TR; Khiatani, D; Tay, HS	1
Comin-Colet, J; Doehner, W; Sindone, A	1
Bhandari, S; Kennedy, NA; Nadaraja, S; Sinclair, RCF; Wakatsuki, M	1
Campos Fernandes, A; Costa, E; Lucas, J; Robalo Nunes, A; Sequeira, R; Sousa, P; Subtil, A	1
Packer, M	1
Aguirre, C; Ceruelo, I; García, M; Palacios-Zabalza, I; Txintxurreta-Albizua, A	1
Aliu, A; Bertrams Maartens, IA; Bevers, N; Escher, H; Oudshoorn, A; Pierik, MJ; Raijmakers, M; Rezazadeh Ardabili, A; Rosias, P; Stapelbroek, J; Teklenburg, S; van de Feen, C; Van de Vijver, E; van Rheenen, PF; Vande Velde, S; Vreugdenhil, A; Winkens, B	1
Ito, N; Kishimoto, U; Ohtani, Y; Sugimura, M; Tamai, S	1
Binnie, R; Cohen-Solal, A; Comin-Colet, J; de Arellano, AR; Dorigotti, F; Harrison, C; Jankowska, EA; Lewis, RD; Lund, LH; McEwan, P; Ohlsson, M; Pascual-Figal, DA; Ponikowski, P; von Haehling, S; Wächter, S	1
Aygün, A; Kaya, Y; Özbilen, M; Savrun, ŞT	1
Pedicino, D; Vergallo, R	1
Lerman, JB; Newby, LK	1
Schaefer, B; Wagner, S; Zoller, H	1
Bhandari, S; Kassianides, X	1
Andreucci, M; Calimeri, S; Cernaro, V; Comi, A; Coppolino, G; Cosentino, S; Donato, C; Leonardi, G; Lucia, CM; Michael, A; Nicotera, R; Provenzano, M	1
Biasi, C; Gambaro, G; Ortalda, V; Rognoni, C	1
Edmonston, D; Wolf, M	1
Gerzeli, S; Rognoni, C	1
Hamano, T	1
Brambilla, AM; Cappellini, MD; Consonni, D; Mantovan, G; Materia, M; Migone De Amicis, M; Montano, N; Motta, I; Porzio, M	1
Hinds, R; Hong, MH; Singh, H	1
Anker, SD; Dorobantu, M; Drozdz, J; Fabien, V; Filippatos, G; Haboubi, T; Jankowska, EA; Keren, A; Khintibidze, I; Kirwan, BA; Kragten, H; Martinez, FA; McDonagh, T; Metra, M; Milicic, D; Nicolau, JC; Ohlsson, M; Parhomenko, A; Pascual-Figal, DA; Ponikowski, P; Ruschitzka, F; Sim, D; Skouri, H; van der Meer, P	1
Amarnani, R; Javaid, MK; Travis, S	1
Ding, Y; Li, C; Li, X; Liu, J; Palmen, M; Roubert, B; Wu, M; Zhang, H; Zhu, X	1
Kiechl-Kohlendorfer, U; Mueller, T; Posod, A; Schaefer, B; Zoller, H	1
Busti, F; Girelli, D; Marchi, G	1
Achebe, M; Brandenburg, V; Carpenter, TO; Econs, MJ; Imel, EA; Peacock, M; Rubin, J; Thomsen, LL; Weber, T; Wolf, M; Zoller, H	1
Loughnane, F; Muduma, G; Pollock, RF	1
Almenar, L; Amiguet, M; Bayés-Genís, A; Bodí, V; Cardells, I; Chorro, FJ; Comín-Colet, J; de la Espriella-Juan, R; Fácila, L; García-Blas, S; González, J; Górriz, JL; Llàcer, P; López-Lereu, MP; López-Vilella, R; Lupón, J; Miñana, G; Monmeneu, JV; Montagud, V; Navarro, J; Núñez, J; Palau, P; Sanchis, J; Serrano, A; Valero, E	1
Caccamo, G; Di Franco, A; Giallauria, F; Nugara, C; Sarullo, FM; Sarullo, S; Vitale, G; Vitale, S	1
Calò, LA; Carraro, G; Cattarin, L; Gobbi, L; Qassim, L; Rigato, M; Rossi, B; Scaparrotta, G	1
Albanesi, M; Caiaffa, MF; Di Bona, D; Di Girolamo, A; Loconte, F; Macchia, L	1
Aczél, S; Bilz, S; Brändle, M; Frei, N; Räss, A; Schoeb, M	1
Amrein, K; Drexler, C; Herster, C; Holter, M; Macher, S; Matzhold, EM; Moritz, M; Pieber, TR; Schlenke, P; Stojakovic, T	1
Ortez-Toro, JJ; Peteiro-Miranda, CM; Román-Gimeno, S; Sanz-Martín, B; Urdaniz-Borque, R	1
Fang, W; Garg, M; Kenny, R; McMahon, LP; Rizvi, QU	1
Álvarez-Pérez, JM; Berrocal-Gil, P; Borraz-Ordás, C; Comabella, R; Comín-Colet, J; Fernández-Cañadas, JM; Ferre, C; Herrero-Puente, P; Jacob, J; Llopis-García, G; Llorens, P; López-Díez, P; Martín-Sánchez, FJ; Martínez-Gimeno, JL; Mercado, A; Miró, Ò; Pérez-Durá, MJ; Richard-Espiga, F; Roset, A; Valero-Domènech, A	1
Beverina, I; Brando, B; Garcia-Erce, JA; Jericó, C; Melli, C; Quintana-Diaz, M; Recasens, V; Rondinelli, MB; Salvadori, U	1
Farland, MZ; Khoury, A; Pagan, KA	1
Böhm, M; Brandenburg, VM; D'Amelio, R; Emrich, IE; Fliser, D; Heine, GH; Kaddu-Mulindwa, D; Lizzi, F; Seiler-Mussler, S; Siegel, JD; Ukena, C; Wagenpfeil, S	1
Allard, M; Bernimoulin, M; Guidard, C; Ozsahin, H; Schaeppi, M; van den Ouweland, F	1
Cai, X; David, V; Frazier, R; Hodakowski, A; Isakova, T; Lee, J; Mehta, R; Stein, B; Wolf, M; Zakarija, A	1
Aiello, A; Berto, P; Conti, P; Panichi, V; Rosati, A	1
Akdeniz, B; Arici, AM; Gelal, A; Kumral, Z	1
Asma, S; Aytan, P; Boğa, C; Büyükkurt, N; Gereklioğlu, Ç; Kasar, M; Korur, A; Özdoğu, H; Solmaz, S; Tanrikulu, FP; Yeral, M	1
DelRosso, LM; Ferri, R; Picchietti, DL	1
Artoni, A; Capecchi, M; Cappellini, MD; La Marca, S; Motta, I; Scaramellini, N	1
Allen, RP; Choi, SJ; Joo, EY; Park, HR	1
Berdot, S; Loustalot, MC; Perrin, G; Pouchot, J; Sabatier, B; Touchard, J	1
Hengartner, H; Mattiello, V; Renella, R; Schmugge, M; von der Weid, N	1
Cepeda, JM; Comín-Colet, J; Delgado, JF; Garcia-Casanovas, A; García-García, JÁ; González-Domínguez, A; González-Franco, Á; Jiménez Merino, S; Oliva, J	1
Kennedy, NA; Schaefer, B; Tilg, H; Tobiasch, M; Viveiros, A; Wolf, M; Zoller, H	1
Anker, SD; Butler, J; Cohen-Solal, A; Comin-Colet, J; Danchin, N; Dargie, HJ; Doehner, W; Dorobantu, M; Drozdz, J; Fabien, V; Filippatos, G; Friede, T; Göhring, UM; Jankowska, EA; Jensen, KH; Keren, A; Khintibidze, I; Kirwan, BA; Kragten, H; Lewis, BS; Martinez, FA; McDonagh, T; Metra, M; Milicic, D; Motro, M; Nicolau, JC; Ohlsson, M; Parkhomenko, A; Pascual-Figal, DA; Pocock, S; Ponikowski, P; Ruschitzka, F; Sim, D; Skouri, H; van der Meer, P; von Haehling, S	1
Barclay, A; Curtis, L; Duncan, H; Fraser, S; Hansen, R; McGuckin, C; Nair, M; Russell, RK; Sasankan, N; Shannon, C	1
Abdulla, S; Asilia, P; Daubenberger, C; Glass, TR; Issa, A; Kuemmerle, A; Lweno, O; Meyer-Monard, S; Mswata, S; Mwebi, KD; Schmidlin, S; Simon, B; Tanner, M; Vanobberghen, F	1
Balla, S; Bianco, C; Faisaluddin, M; Kheiri, B; Osman, M; Syed, M	1
Balta, D; Farmakis, D; Karavidas, A; Karavidas, IN; Lazaros, G; Parissis, J; Polyzogopoulou, E; Troganis, E	1
Bennett, A; Chunilal, S; Coughlin, E; Dev, A; Gilbertson, M; Indran, T; Opat, S; Pasricha, SR; van Dam, M	1
Akobeng, AK; Allen, P; Engineer, J; Gordon, M; Hoque, S; Iheozor-Ejiofor, Z; Iqbal, T; Sinopoulou, V	1
Aksan, A; Dignass, A; Stein, J	2
Patrono, C; Volpe, M	1
Antonioli, L; Baiano Svizzero, G; Bellini, M; Bertani, L; Blandizzi, C; Coppini, F; de Bortoli, N; Marchi, S; Tricò, D; Zanzi, F	1
Bernhardt, MB; Kirk, SE; Mahoney, DH; Powers, JM; Scheurer, ME	1
Borrelli, O; Chadokufa, S; Cococcioni, L; El-Khouly, S; Kiparissi, F; McCartney, S; Pensabene, L; Saliakellis, E	1
Di Lenarda, A; Nesti, U; Sciatti, E	1
DeFilippis, EM; Van Spall, HGC	1
Aloni, A; Beverina, I; Brando, B; Gatti, F; Varalli, L	1
Bokemeyer, B; Domènech, E; Howaldt, S; Martinez, N; Schmidt, C	1
Ambrosy, AP; Butler, J; De Pasquale, CG; Dugan, M; Ezekowitz, JA; Garg, J; Hernandez, AF; Leloudis, D; Lewis, GD; Mentz, RJ; Mundy, LM; O'Meara, E; Rockhold, FW; Samsky, MD; Troughton, RW; Wong, YW	1
Choi, YJ; Go, DY; Jang, YK; Ko, EJ; Lee, SW; Shin, HW; You, HS	1
Anker, SD; Butler, J; Cohen-Solal, A; Comin-Colet, J; Danchin, N; Dargie, HJ; Doehner, W; Dorigotti, F; Dorobantu, M; Drozdz, J; Fabien, V; Filippatos, G; Friede, T; Jankowska, EA; Keren, A; Khintibidze, I; Kirwan, BA; Kosiborod, M; Kragten, H; Lewis, BS; Martinez, FA; McDonagh, T; Metra, M; Milicic, D; Motro, M; Nicolau, JC; Ohlsson, M; Parkhomenko, A; Pascual-Figal, DA; Pocock, S; Ponikowski, P; Ruschitzka, F; Sim, D; Skouri, H; van der Meer, P; von Haehling, S	1
Ikuta, K	1
Allen, RP; Bae, H; Cho, YW; Earley, CJ; Kim, KT	1
Amezcua-Prieto, C; Daru, J; Godolphin, PJ; Khan, KS; Nicolaides, M; Robinson, S; Rogozińska, E; Saborido, CM; Thangaratinam, S; Wang, R; Zamora, J	1
Acheson, AG; Al-Hassi, HO; Brookes, MJ; Evstatiev, R; Gasche, C; Jambrich, M; Keeler, B; Khare, V; Mangalika, M; Ng, O; Phipps, O; Worton, N	1
Gupte, SA; Jangam, SM; Mudholkar, AS; Shah, AS; Venkataraman, G	1
Clarke, NA; Elliott, AD; Emami, M; Gallagher, C; Hanna-Rivero, N; Lau, DH; Lyrtzis, E; Mishima, RS; Roberts-Thomson, KC; Sanders, P; Stokes, MB; Tu, SJ; Wlochowicz, D; Wong, CX	1
Abdullah, MAJ; AbuMousa, R; Adel, AA; Aldapt, MB; Basha, A; Chandra, P; Ekeibed, Y; Hamad, A; Hussein, RM; Ibrahim, MIM; Mahfouz, A; Omar, NE; Shwaylia, HM; Yassin, MA	1
Bock, AH; Carrera, F; Cronin, M; Eckardt, KU; Gaillard, CA; Larroque, S; Macdougall, IC; Meier, Y; Roger, SD; Van Wyck, DB	1
Anker, SD; Arutyunov, GP; Comin-Colet, J; Filippatos, G; Kirwan, BA; Lüscher, TF; Mori, C; Motro, M; Pocock, SJ; Ponikowski, P; Roubert, B; Ruschitzka, F; van Veldhuisen, DJ	1
Borgeaud, M; Perrier, A	1
Anabitarte, P; Gstrein, C; Meyer, M	1
Grigoriadis, G; Low, MS	1
Boccia, S; Di Pietro, ML; Fabrizio, L; Favaretti, C; Gasbarrini, A; Kheiraoui, F; Poscia, A; Proli, EM; Scaldaferri, F; Stojanovic, J; Volpe, M	1
Gaynor, E; Howarth, L; Rodrigues, A; Tan, MLN; Thornton, G; Windscheif, PM	1
Grivell, RM; Grzeskowiak, LE; Mol, BW; Qassim, A	1
Breymann, C; Honegger, C; Hösli, I; Surbek, D	1
Borrelli, S; Conte, G; De Nicola, L; Garofalo, C; Liberti, ME; Minutolo, R; Sagliocca, A	1
Li, T; Yu, Z	1
Kim, YW; Yang, H	1
Katz, SD	1
Gandhi, K; Hokabaj, S; Mishra, V; Roy, P; Shah, KN	1
Muduma, G; Pollock, RF	4
Stewart Coats, AJ	1
Singler, K	1
Epstein, J; Fell, JME; Goto, E; Korologou-Linden, R; Papadopoulos, M; Patel, D; Soondrum, K	1
Asaad, S; Econs, M; Klein, K; Rubin, JE	1
Ara, R; Bader, GN; Naqash, A	1
Ching, A; Cushway, T; Hadi, FA; Lam, CSP; Lee, KY; Li, R; Lim, SL; Loh, SY; Richards, AM; Tai, BC; Wong, RC; Yeo, PSD; Yeo, TJ; Yin, FF	1
Aggarwal, R; Choudhary, S; Gandhi, K; Mishra, V; Roy, P; Sokabaj, S	1
Ikuta, K; Kawabata, Y; Shimura, A; Terauchi, M; Yoshii, K	1
Adkinson, NF; Auerbach, M; Bernard, KE; Chertow, GM; Kaper, RF; Krop, JS; Macdougall, IC; Strauss, WE	1
Arkkila, P; Färkkilä, M; Haapamäki, J; Kangaspunta, M	1
Cutts, BA; Gilmartin, CE; Hoang, T; Leung, L	1
Abergel, A; Aumaitre, O; Bagel, S; Boisgard, S; Delpeuch, A; Ruivard, M; Sautou, V	1
Scott, LJ	1
Almenar, L; Amiguet, M; Bayés-Genís, A; Bodí, V; Cardells, I; Chorro, FJ; de la Espriella-Juan, R; Fácila, L; García-Blas, S; González, J; Llàcer, P; López-Lereu, MP; López-Vilella, R; Miñana, G; Monmeneu, JV; Montagud, V; Núñez, J; Palau, P; Sanchis, J; Serrano, A; Valero, E	1
Dekker, G; Froessler, B; Gajic, T; Hodyl, NA	2
Brandenburg, V; Heine, GH; Marx, N; Sandstede, L; Stöhr, R	1
Azouza, W; Boustany, R; Chanet, B; Coussirou, J; De Crozals, F; Debourdeau, A; Debourdeau, P; Jean, C; Stancu, A	1
Ascanio, M; Darbà, J	1
Aksan, A; Dignass, A; Klemm, W; Nip, K; Stein, J; Weber-Mangal, S	1
Mundy, LM; Wohlfeil, S	1
Auerbach, M; Chertow, GM; Franklin Adkinson, N; Kaper, RF; Krop, JS; Macdougall, IC; Strauss, WE	1
Choorapoikayil, S; Füllenbach, C; Glaser, P; Meybohm, P; Triphaus, C; Zacharowski, K; Ziebart, A	1
Basora, M; Coca, M; Lozano, L; Pereira, A; Tió, M	1
Hanashi, H; Hirai, K; Ikuta, K; Matsuyama, Y; Momoeda, M; Ota, Y; Shimura, A; Terauchi, M	1
Lichtenstein, GR; Onken, JE	1
Cho, YK; Jun, JK; Kim, A; Kim, MY; Kim, YJ; Lee, JJ; Lee, KY; Lee, Y; Shim, JY; Shin, JC; Song, TB	1
Ikuta, K; Ito, H; Masaki, S; Suzuki, Y; Takahashi, K; Terauchi, M	1
Dasseni, N; Dinatolo, E; Lombardi, C; Metra, M; von Haehling, S	1
Bakker, SJL; Diepenbroek, A; Eisenga, MF; Franssen, CFM; Gaillard, CAJM; Hofman, JMG; Nolte, IM; van Dam, B; Westerhuis, R	1
Abdelazim, IA; Nusair, B; Svetlana, S; Zhurabekova, G	1
Birnie, E; Mulder, MB; van den Hoek, HL; van Tilburg, AJP; Westerman, EM	1
Cabrales Alin, D; Hofmarcher, T; Linde, C	1
García-Erce, JA; Lorente Aznar, T; Rivilla Marugán, L	1
Allen, JC; Chuang, A; Dennis, A; Falloon, P; Gray, Z; Hanna, F; Hyppa, A; Khalafallah, AA; Kwok, C; Mathew, R; Pavlov, T; Wilson, E; Yan, C	1
Chertow, GM; Kaper, R; Krop, J; Macdougall, IC; Strauss, W; Wolf, M	1
Anker, SD; Ebner, N; Evertz, R; Ponikowski, P; von Haehling, S	1
Bhatla, N; Jose, A; Kalaivani, M; Kriplani, A; Mahey, R; Saxena, R; Sharma, JB	1
Chung, YJ; Lakhal-Littleton, S; Loonat, AA; Luo, A; Park, KC; Robbins, PA; Swietach, P	1
Bedouch, P; Romanet, T; Zaoui, P	1
Fava, C; Piepoli, M; Villani, GQ	1
Diebold, M; Kistler, AD	1
Lee, AYS; Leung, SHP	1
Kim, T; Lee, ES; Lee, JJ; Lee, KH; Lee, S; Ryu, KJ	1
El-Zaatari, MS; Hassan-Smith, ZK; Reddy-Kolanu, V	1
Amrein, K; Drexler, C; Holter, M; Lindenau, I; Macher, S; Moritz, M; Pieber, TR; Schlenke, P; Stojakovic, T	1
Falk, V; Hegemann, I; Hofmann, A; Kaserer, A; Maisano, F; Schoenrath, F; Seifert, B; Spahn, DR; Spahn, GH; Stein, P; Theusinger, OM	1
Macdougall, IC	2
Crowley, CM; Desmond, J; Imcha, M; McMahon, G	1
Detlie, TE; Finnes, E; Jahnsen, J; Jahnsen, ME; Lindstrøm, JC; Moum, B; Zoller, H	1
Bregman, DB; Koch, TA; Wolf, M	1
Barish, C; Bregman, D; He, A; Malone, M	1
Derry, D; Kathiresan, B; Waine, D	1
Anker, SD; Conraads, VM; Gaudesius, G; Greenlaw, N; Mori, C; Ponikowski, P; Van Craenenbroeck, EM	1
Cabré, C; Font, R; García-Ruiz, C; Jariod, M; Martínez-Vea, A; Muñoz-Cortés, M; Nogués, MR; Prats, M; Romeu, M	1
Evstatiev, R; Gasche, C; Howaldt, S; Kamali, H; Kulnigg-Dabsch, S; Mickisch, O; Schmid, W; Stein, J; Volf, I; Waldhör, T	1
Biggar, P; Hahn, KM	1
Amet, S; Deray, G; Janus, N; Launay-Vacher, V; Mahi, L; Rey, JB; Rouillon, L; Scotte, F; Zakin, L	1
Münch, HG; Potthoff, SA	1
Acs, P; Akright, B; Barish, C; Bhaskar, BS; Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Smith-Nguyen, GN	1
Anker, SD; Colet, JC; Dickstein, K; Farmakis, D; Filippatos, G; Ford, I; Gaudesius, G; Greenlaw, N; Lüscher, TF; Mori, C; Parissis, J; Ponikowski, P; von Eisenhart Rothe, B; Willenheimer, R	1
Weiss, G	1
Gifford, AH	1
Anker, SD; Braunhofer, PG; Comin-Colet, J; Filippatos, G; Gutzwiller, FS; Mori, C; Pfeil, AM; Ponikowski, P; Schwenkglenks, M; Szucs, TD	1
Achermann, R; Giger, M	1
Thompson, CA	1
Li, Y; Wang, H; Zhu, W; Zuo, L	1
Gasche, C; Kulnigg-Dabsch, S	1
Bregman, DB; Buerkert, J; Butcher, A; Goodnough, LT; Hamerski, D; Harrington, RA; Iftikhar, H; Koch, TA; Mangoo-Karim, R; Martin, ER; Martinez, CO; Morris, D; Newman, GE; Onken, JE; Qunibi, WY; Ross, DL; Singh, B; Smith, MT	1
Braunhofer, P; Brock, E; Schneider, H; Troxler, J	1
Gisbert, JP; Gomollón, F	2
Bock, A; Carrera, F; Cushway, T; Eckardt, KU; Gaillard, C; Macdougall, IC; Roger, SD; Roubert, B; Van Wyck, D	1
Coyne, DW; Larson, DS	1
Barea Mendoza, JA; González Olmedo, J; Gredilla Zubiría, I; Mateo Alvarez, S	1
Coti Bertrand, P; Fierz, YC; Gonthier, A; Kenmeni, R; Lier, F; Pralong, F	1
Collingwood, J; Dekker, G; Froessler, B; Hodyl, NA	1
Cabré, C; Font, R; García, C; Giralt, M; Jariod, M; Martinez-Vea, A; Muñoz-Cortés, M; Prats, M; Romeu, M	1
Anker, SD; von Haehling, S	1
Hiller, E	1
Baldus, S; Dumitrescu, D; Gerhardt, F; Knoop-Busch, S; Rosenkranz, S; Rudolph, TK; ten Freyhaus, H; Viethen, T	1
Bock, AH; Carrera, F; Eckardt, KU; Gaillard, C; Macdougall, IC; Nolen, JG; Roger, SD; Roubert, B; Van Wyck, D	1
Fishbane, S; Hazzan, AD	1
Allocca, M; Danese, S; Fiorino, G	1
Chainey, S; Cushway, T; Laass, MW; Straub, S; Virgin, G	1
Bach, M; Geisel, T; Röhrig, G; Schaefer, R; Schulz, RJ; Stein, J; Steinmetz, T; Virgin, G	1
Birgegård, G; Felder, M; Hedenus, M; Karlsson, T; Ludwig, H; Roubert, B; Rzychon, B	1
Keating, GM	1
Gasche, C; Iqbal, T; Kulnigg-Dabsch, S; Sharma, N; Stein, J; Vel, S	1
Angerosa, M; Toblli, JE	1
Fuertes Martín, A; Inés Revuelta, S; Moralejo Alonso, L; Sánchez González, R; Ternavasio-de la Vega, HG	1
Anker, SD; Comín-Colet, J; Enjuanes-Grau, C; Gutzwiller, FS; Ponikowski, P; Rubio-Rodríguez, D; Rubio-Terrés, C	1
Anker, SD; Colet, JC; Dickstein, K; Filippatos, G; Ford, I; Gaudesius, G; Greenlaw, N; Lüscher, T; Macdougall, I; Mori, C; Ponikowski, P; von Eisenhart Rothe, B; Willenheimer, R	1
Češka, R	1
Jamieson, A; Mattinson, A; Pelosi, AJ	1
Barrière, J; Bugat, R; Concas, VH; Duvillié, L; Huot-Marchand, P; Laribi, K; Luporsi, E; Morere, JF; Scotté, F; Toledano, A	1
Arneth, B; Bornstein, SR; Heigl, F; Hettich, R; Illigens, BM; Julius, U; Prophet, H; Ramlow, W; Schatz, U; Siegels, D; Siegert, G; Siepmann, T	1
Borrás-Blasco, J; Boscá, M; Cortés, E; Cortes, X; Molés, JR	1
Bemelman, WA; Borstlap, WAA; Buskens, CJ; C A Wientjes, CA; Consten, ECJ; de Castro, SMM; Dijkgraaf, MGW; Gerhards, MF; Heuff, G; Jansen, J; Kennelly, RP; Omloo, JM; Tanis, PJ; Tolboom, RC; Tuynman, JB; Tytgat, KMAJ; van der Ven, AWH; van der Zaag, E; van Geloven, N; van Wagensveld, BA; van Westreenen, HL; Winter, DC	1
de Teresa, E; García-Pinilla, JM; Gómez-Doblas, JJ; González-Cruces, N; Morcillo-Hidalgo, L; Robledo-Carmona, J; Robles-Mezcua, A; Ruiz-Salas, A	1
ÀngelRuíz, M; Calleja, JL; Calvet, X; Cucala, M; Delgado, S; Figuerola, A; Gené, E; Mearin, F; Villoria, A	1
Bassetti, C; Baumann, C; Gyr, T; Hübner, A; Krafft, A; Manconi, M; Schneider, J; Werth, E	1
Koch, TA; Okam, MM; Tran, MH	1
Fajt, ML; Montandon, SV; Petrov, AA	1
Froessler, B; Hodyl, NA; Murphy, EM; Palm, P; Singh, R; Weber, I	1
Cançado, RD; Frugis, MO; Sobrado, CW; Sobrado, LF; Sobrado, MF	1
Bhatla, N; Kachhawa, G; Kriplani, A; Mahey, R; Mogili, KD; Saxena, R	1
Bajador, E; Bocos, JM; Castaño, C; Chaparro, M; García-Erce, JA; García-López, S; Gisbert, JP; Gomollón, F	1
Fell, LH; Fliser, D; Heine, GH; Rotter, B; Seiler-Mußler, S; Sellier, AB; Sester, M; Winter, P; Zawada, AM	1
Girrbach, G	1
Coyne, DW; Daloul, R; Pandey, R	1
Ghaly, S	1
Bansal, SS; Bock, AH; Carrera, F; Cronin, M; Eckardt, KU; Gaillard, CA; Larroque, S; Macdougall, IC; Meier, Y; Roger, SD; Van Wyck, DB	1
Bernard, R; Breymann, C; Dudenhausen, J; Mezzacasa, A; Milman, N	1
Agrogiannis, I; Drakou, A; Margeli, A; Papassotiriou, I; Poziopoulos, C; Theodorakopoulou, S; Vlahakos, DV	1
Al-Badri, R; Gray, Z; Ingram, E; Khalafallah, AA; Khelgi, V; Kirkby, BE; Kirkby, BP; Robertson, IK; Robinson, E; Yan, C	1
Lopes, AI; Maltez, C; Valério de Azevedo, S	1
Al-Khaffaf, A; Capelli, S; Melli, C; Polese, F; Salvadori, U; Sandri, M; Simeoni, M	1
Bruder, O; Hambrecht, R; Hochadel, M; Maeder, MT; Michel, S; Pauschinger, M; Pfister, O; Remppis, BA; Senges, J; Strasser, R; von Scheidt, W; Wienbergen, H	1
Adix, L; Buchanan, GR; McCavit, TL; Powers, JM; Shamoun, M	1
Berger, SP; Daha, MR; de Vlaam, TP; Franssen, CF; Gaillard, CA; Gaya da Costa, M; Hempel, JC; Poppelaars, F; Seelen, MA	1
Braithwaite, V; Effenberger, M; Finkenstedt, A; Griesmacher, A; Moschen, A; Schaefer, B; Sulzbacher, I; Tilg, H; Viveiros, A; Vogel, W; Würtinger, P; Zoller, H	1
Plate, A	1
Bakker, SJ; Eisenga, MF; Gaillard, CA	1
Acheson, AG; Brookes, MJ; Keeler, BD; Ng, O; Padmanabhan, H; Simpson, JA	1
Borobia, AM; García-Erce, JA; Gómez-Ramírez, S; Muñoz, M; Muñoz-Romo, R; Pavía, J; Quintana-Díaz, M	1
Mantadakis, E; Roganovic, J	1
Baker, JB; Banach, W; Derman, RJ; Goldberg, C; Rogers, R; Seid, MH	1
Cohen, CD; Fehr, T; Grimmelt, AC; Serra, AL; Wuethrich, RP	1
Keating, GM; Lyseng-Williamson, KA	1
Goodnough, LT; Hadley, PE; Jehle, JA; Mangione, A; Morrison, J; Van Wyck, DB	1
Anker, SD; Colet, JC; Dickstein, K; Drexler, H; Filippatos, G; Lüscher, TF; Mori, C; Pocock, S; Ponikowski, P; Poole-Wilson, PA; von Eisenhart Rothe, B; Willenheimer, R	1
Bailie, GR; Mason, NA; Valaoras, TG	1
Dec, GW	1
Anker, SD; Banasiak, W; Bart, B; Comin Colet, J; Dickstein, K; Drexler, H; Filippatos, G; Kirwan, BA; Lüscher, TF; Mori, C; Niegowska, J; Pocock, SJ; Ponikowski, P; Poole-Wilson, PA; von Eisenhart Rothe, B; Willenheimer, R	1
Covic, A; Mircescu, G	1
Jelani, QU; Katz, SD	1
Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Szczech, LA; Wolf, M	1
Marx, JJ	1
Banké-Bochita, J; Geisser, P	1
Bailie, GR	1
Geisser, P; Rumyantsev, V	1
Benjamin, J; Mangione, A; Martinez, C; Qunibi, WY; Roger, SD; Smith, M	1
Bager, P; Dahlerup, JF	1
Gozzard, D	1
Cowie, MR; Lucas, R	2
Bokemeyer, B; Chopey, IV; Evstatiev, R; Gasche, C; Gutzwiller, FS; Iqbal, T; Khalif, IL; Marteau, P; Riopel, L; Stein, J	1
Beigel, F; Brand, S; Breiteneicher, S; Göke, B; Laubender, RP; Löhr, B; Ochsenkühn, T; Schnitzler, F; Seiderer, J; Tillack, C; Weidinger, M	1
Anker, SD; Comin-Colet, J; Dickstein, K; Filippatos, GS; Johnson, P; Lainscak, M; Lüscher, TF; Mori, C; Ponikowski, P; Willenheimer, R	1
Andersson, M; Kurtzhals, JA; Maretty, L; Sharp, RE	1
Martín-Montañez, E; Muñoz, M	1
Hoo, ZH; Wildman, MJ	1
Christoph, P; Pfenniger, A; Schuller, C; Surbek, D	1
Bhandari, S; Muñoz, M; Reinisch, W; Staun, M	1
Hutchings, A; Jeans, A; Macdougall, IC; Wilson, PD	1
Calvet, X; Dosal, A; Figuerola, A; Gené, E; López, M; Miquel, M; Moreno, L; Ruíz, MÀ; Suarez, D; Villoria, A	1
Franzem, M; Harlin, O; Klement, B; Marschner, N; Rohrberg, R; Steinmetz, T; Tesch, H; Tschechne, B; Wamhoff, J	1
Alexeeva, O; Bokemeyer, B; Chopey, I; Evstatiev, R; Felder, M; Gasche, C; Gudehus, M; Iqbal, T; Khalif, I; Marteau, P; Stein, J	1
Anderson, GJ; Bell, SC; Lamont, IL; Masel, P; Reid, DW; Smith, DJ	1
Bernardo, MV; Bregman, DB; Butcher, A; Charytan, C; Koch, TA; Morris, D	1
Geisser, P; Macdougall, IC	1
Bregman, DB; Goodnough, LT; He, A; Koch, TA; Morris, D	1
Arneth, B; Bornstein, SR; Fischer, S; Julius, U; Schatz, U; Siegels, D; Siegert, G	1
Mehta, BC	1
Bejenariu, C; Breymann, C; Gliga, F; Strizhova, N	1
D'Haens, G; Dudar, LV; Garcia, LC; Gasche, C; Karnafel, W; Kulnigg, S; Sambuelli, AM; Simanenkov, V; Stoinov, S	1
Birgegård, G; Hedenus, M	1

Reviews

46 review(s) available for acebutolol and Anemia, Iron-Deficiency

Article	Year
Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of gestational and peripartum anaemia in Spain. BMC pregnancy and childbirth, 2022, Feb-25, Volume: 22, Issue:1 Topics: Anemia, Iron-Deficiency; Decision Support Techniques; Female; Ferric Compounds; Ferrous Compounds; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Risk Assessment; Spain; Stakeholder Participation	2022
Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials. Pharmacological research, 2022, Volume: 182 Topics: Anemia, Iron-Deficiency; Dietary Supplements; Heart Failure; Humans; Iron; Iron Deficiencies; Maltose; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2022
A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose. Advances in therapy, 2022, Volume: 39, Issue:10 Topics: Anemia, Iron-Deficiency; Cardiovascular Diseases; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Heart Failure; Humans; Incidence; Iron; Maltose; Randomized Controlled Trials as Topic	2022
Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency. Nutrients, 2022, Aug-05, Volume: 14, Issue:15 Topics: Anemia, Iron-Deficiency; Chronic Disease; Comorbidity; Ferric Compounds; Heart Failure; Humans; Iron; Iron Deficiencies; Maltose; Quality of Life	2022
Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review. European journal of pediatrics, 2022, Volume: 181, Issue:11 Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Iron; Iron Deficiencies; Maltose; Prospective Studies; Retrospective Studies; Treatment Outcome	2022
Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency. ESC heart failure, 2023, Volume: 10, Issue:1 Topics: Anemia, Iron-Deficiency; Hematinics; Humans; Iron; Iron Deficiencies; Maltose	2023
Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor-23. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2020, Volume: 24, Issue:3 Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Ferric Compounds; Fibroblast Growth Factor-23; Hematinics; Humans; Hypophosphatemia; Long Term Adverse Effects; Maltose	2020
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nature reviews. Nephrology, 2020, Volume: 16, Issue:1 Topics: Anemia, Iron-Deficiency; Bone and Bones; Calcium; Erythropoiesis; Familial Hypophosphatemic Rickets; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Inflammation; Iron; Maltose; Phosphates; Protein Processing, Post-Translational; Renal Insufficiency, Chronic; RNA, Messenger; Transcription, Genetic	2020
[The beneficial effects of iron supplementation other than improvement of anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:9 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Heart Failure; Humans; Iron; Maltose; Mice; Randomized Controlled Trials as Topic; Receptors, Transferrin	2019
Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults. The Annals of pharmacotherapy, 2021, Volume: 55, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Clinical Trials as Topic; Female; Ferric Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Renal Insufficiency, Chronic; Treatment Outcome	2021
Economic impact of ferric carboxymaltose in haemodialysis patients Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2020, 08-03, Volume: 37, Issue:Suppl 75 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Hematinics; Humans; Iron Deficiencies; Iron Metabolism Disorders; Maltose; Renal Dialysis	2020
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis. British journal of clinical pharmacology, 2021, Volume: 87, Issue:5 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Maltose; Prospective Studies	2021
A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure. The American journal of cardiology, 2021, 02-15, Volume: 141 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Cardiovascular Diseases; Cause of Death; Ferric Compounds; Heart Failure; Hematinics; Hospitalization; Humans; Maltose; Mortality; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome	2021
Interventions for treating iron deficiency anaemia in inflammatory bowel disease. The Cochrane database of systematic reviews, 2021, Jan-20, Volume: 1 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Bias; Colitis, Ulcerative; Crohn Disease; Disaccharides; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fumarates; Hematinics; Humans; Iron Compounds; Maltose; Middle Aged; Placebos; Pyrones; Randomized Controlled Trials as Topic; Young Adult	2021
Indirect comparison between ferric carboxymaltose and oral iron replacement in heart failure with reduced ejection fraction: a network meta-analysis. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2021, Mar-31, Volume: 91, Issue:3 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose; Network Meta-Analysis	2021
Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis. Medicine, 2021, May-21, Volume: 100, Issue:20 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Hematinics; Hemoglobins; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Randomized Controlled Trials as Topic; Treatment Outcome	2021
[The newest information for iron metabolism: ferric carboxymaltose, a recently available treatment option for iron-deficiency anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2021, Volume: 62, Issue:5 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Iron; Japan; Maltose; Treatment Outcome	2021
Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. The Lancet. Haematology, 2021, Volume: 8, Issue:7 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Maltose; Nausea; Pregnancy	2021
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. European journal of heart failure, 2018, Volume: 20, Issue:1 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Global Health; Heart Failure; Hospitalization; Humans; Iron; Iron Deficiencies; Maltose; Survival Rate	2018
Iron deficiency and new insights into therapy. The Medical journal of Australia, 2017, Jul-17, Volume: 207, Issue:2 Topics: Administration, Oral; Anemia, Iron-Deficiency; Australia; Blood Transfusion; Bone Marrow; Child; Female; Ferric Compounds; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Maltose; Pregnancy	2017
Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review. The Australian & New Zealand journal of obstetrics & gynaecology, 2018, Volume: 58, Issue:1 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Quality of Life	2018
[Iron deficiency in ND-CKD: from diagnosis to treatment]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2017, Sep-28, Volume: 34, Issue:5 Topics: Anemia, Iron-Deficiency; Biomarkers; Bone Marrow Examination; Erythropoiesis; Ferric Compounds; Ferritins; Gastrointestinal Hemorrhage; Hematinics; Hemoglobins; Hepcidins; Humans; Intestinal Absorption; Iron; Iron Deficiencies; Maltose; Multicenter Studies as Topic; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Reticulocytes; Transferrin	2017
[Iron, a "miralcle cure" for chronic cardiac insufficiency?] Zeitschrift fur Gerontologie und Geriatrie, 2018, Volume: 51, Issue:2 Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; Ferric Compounds; Heart Failure; Hemoglobinometry; Humans; Iron Compounds; Male; Maltose; Reference Values; Transferrin	2018
Ferric Carboxymaltose: A Review in Iron Deficiency. Drugs, 2018, Volume: 78, Issue:4 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Chronic Disease; Female; Ferric Compounds; Heart Failure; Humans; Inflammatory Bowel Diseases; Kidney Diseases; Maltose; Neoplasms; Postpartum Period; Pregnancy; Treatment Outcome; Uterine Hemorrhage	2018
Iron deficiency in heart failure. Journal of cardiovascular medicine (Hagerstown, Md.), 2018, Volume: 19, Issue:12 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Comorbidity; Ferric Compounds; Heart Failure; Humans; Maltose; Meta-Analysis as Topic; Quality of Life; Randomized Controlled Trials as Topic	2018
Iron Deficiency in Heart Failure: An Overview. JACC. Heart failure, 2019, Volume: 7, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Cardiovascular Diseases; Comorbidity; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Heart Failure; Hematinics; Hemoglobins; Hospitalization; Humans; Maltose; Oxygen Consumption; Prevalence; Quality of Life; Stroke Volume; Transferrin; Walk Test	2019
A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment. Expert review of hematology, 2019, Volume: 12, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Hematinics; Hemoglobins; Humans; Maltose	2019
[Heart failure and iron deficiency]. Giornale italiano di cardiologia (2006), 2019, Volume: 20, Issue:3 Topics: Aged; Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron Deficiencies; Maltose; Quality of Life; Stroke Volume	2019
[Importance of the different i.v. iron generations for everyday medical practice]. MMW Fortschritte der Medizin, 2013, Mar-21, Volume: 155 Suppl 1 Topics: Anemia, Iron-Deficiency; Disaccharides; Dose-Response Relationship, Drug; Drug Substitution; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Structure-Activity Relationship; Treatment Outcome	2013
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24 Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis	2013
Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs, 2013, Volume: 73, Issue:16 Topics: Anemia, Iron-Deficiency; Animals; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Iron; Maltose	2013
Update on intravenous iron choices. Current opinion in nephrology and hypertension, 2014, Volume: 23, Issue:2 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferrosoferric Oxide; Hematinics; Homeostasis; Humans; Intestinal Absorption; Maltose; Renal Insufficiency, Chronic; Treatment Outcome	2014
[Iron deficiency in chronic heart failure: from diagnosis to therapy]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:16 Topics: Anemia, Iron-Deficiency; Comorbidity; Diagnosis, Differential; Drug Dosage Calculations; Exercise Tolerance; Ferric Compounds; Heart Failure; Hemoglobinometry; Humans; Infusions, Intravenous; Maltose; Quality of Life	2014
Iron deficiency: the hidden miscreant in inflammatory bowel disease. Current drug targets, 2014, Volume: 15, Issue:11 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Maltose; Quality of Life	2014
Ferric carboxymaltose: a review of its use in iron deficiency. Drugs, 2015, Volume: 75, Issue:1 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Injections, Intravenous; Maltose	2015
Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose. Drug design, development and therapy, 2014, Volume: 8 Topics: Anemia, Iron-Deficiency; Drug Delivery Systems; Ferric Compounds; Humans; Maltose	2014
[Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:12 Topics: Anemia, Iron-Deficiency; Cardiology; Clinical Protocols; Female; Ferric Compounds; Gastroenterology; Heart Failure; Humans; Male; Maltose; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome	2014
Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica, 2016, Volume: 101, Issue:1 Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Iron; Male; Maltose; Randomized Controlled Trials as Topic	2016
Iron Treatment Strategies in Dialysis-Dependent CKD. Seminars in nephrology, 2016, Volume: 36, Issue:2 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Renal Dialysis; Transferrin	2016
Iron Treatment Strategies in Nondialysis CKD. Seminars in nephrology, 2016, Volume: 36, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Maltose; Renal Insufficiency, Chronic; Severity of Illness Index; Transferrin	2016
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs, 2009, Volume: 69, Issue:6 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Hematinics; Humans; Maltose; Randomized Controlled Trials as Topic; Treatment Outcome	2009
When is high-dose intravenous iron repletion needed? Assessing new treatment options. Drug design, development and therapy, 2011, Jan-20, Volume: 5 Topics: Anemia, Iron-Deficiency; Animals; Disaccharides; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferric Compounds; Hemorrhage; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Maltose	2011
Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected]. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:6 Topics: Administration, Oral; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Follow-Up Studies; Humans; Maltose; Mouth Mucosa; Randomized Controlled Trials as Topic	2012
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's & colitis, 2013, Volume: 7, Issue:6 Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism	2013
Use of intravenous iron supplementation in chronic kidney disease: an update. Iranian journal of kidney diseases, 2013, Volume: 7, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferrosoferric Oxide; Hematinics; Humans; Iron-Dextran Complex; Maltose; Renal Dialysis; Renal Insufficiency, Chronic	2013
The role of iron supplementation during epoietin treatment for cancer-related anemia. Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1 Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic	2009

Trials

78 trial(s) available for acebutolol and Anemia, Iron-Deficiency

Article	Year
Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN, 2021, Volume: 16, Issue:10 Topics: Adult; Aged; Anemia, Iron-Deficiency; Austria; Biomarkers; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Transferrin; Treatment Outcome	2021
Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial. Blood transfusion = Trasfusione del sangue, 2022, Volume: 20, Issue:4 Topics: Administration, Intravenous; Anemia; Anemia, Iron-Deficiency; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Iron; Maltose	2022
Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial. BMJ open, 2021, 11-23, Volume: 11, Issue:11 Topics: Anemia; Anemia, Iron-Deficiency; Australia; Female; Ferric Compounds; Humans; Malawi; Maltose; Multicenter Studies as Topic; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Standard of Care	2021
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial. Archivos de bronconeumologia, 2022, Volume: 58, Issue:10 Topics: Anemia, Iron-Deficiency; Exercise Tolerance; Ferric Compounds; Ferritins; Humans; Iron; Iron Deficiencies; Maltose; Pulmonary Disease, Chronic Obstructive; Quality of Life; Single-Blind Method; Transferrins; Treatment Outcome	2022
Testing equivalence of two doses of intravenous iron to treat iron deficiency in pregnancy: A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 2023, Volume: 130, Issue:1 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Iron; Iron Deficiencies; Maltose; Pregnancy	2023
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial. The Journal of pediatrics, 2023, Volume: 256 Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Treatment Outcome	2023
Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single-arm, open-label, phase 3 study in Japan. The journal of obstetrics and gynaecology research, 2023, Volume: 49, Issue:3 Topics: Adult; Anemia, Iron-Deficiency; Depression, Postpartum; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Infant, Newborn; Iron; Japan; Maltose; Postpartum Hemorrhage; Pregnancy	2023
Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD. Scientific reports, 2023, 10-26, Volume: 13, Issue:1 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Humans; Iron; Maltose; Patient Reported Outcome Measures; Pulse Wave Analysis; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic	2023
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. European journal of heart failure, 2019, Volume: 21, Issue:12 Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Inpatients; Male; Maltose; Middle Aged; Quality of Life; Retrospective Studies; Survival Rate; Switzerland; Treatment Outcome	2019
Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia. Clinical therapeutics, 2020, Volume: 42, Issue:2 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Asian People; Female; Ferric Compounds; Ferritins; Humans; Iron; Male; Maltose	2020
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA, 2020, 02-04, Volume: 323, Issue:5 Topics: Adult; Anemia, Iron-Deficiency; Biomarkers; Disaccharides; Female; Ferric Compounds; Headache; Hematinics; Humans; Hypophosphatemia; Incidence; Male; Maltose; Middle Aged; Nausea; Phosphates	2020
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. Journal of the American Heart Association, 2020, 02-18, Volume: 9, Issue:4 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Hematinics; Humans; Iron; Magnetic Resonance Imaging; Male; Maltose; Middle Aged; Myocardium	2020
The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT. Nutrients, 2020, May-05, Volume: 12, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Blood Donors; Dietary Supplements; Fatigue Syndrome, Chronic; Female; Ferric Compounds; Humans; Infusions, Intravenous; Iron, Dietary; Male; Maltose; Middle Aged; Quality of Life; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome; Young Adult	2020
Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study. BMC medicine, 2020, 07-13, Volume: 18, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Iron; Male; Maltose; Prospective Studies	2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet (London, England), 2020, 12-12, Volume: 396, Issue:10266 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Hospitalization; Humans; Male; Maltose; Middle Aged; Patient Discharge; Treatment Outcome; Ventricular Function, Left	2020
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. The Lancet. Global health, 2021, Volume: 9, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Folic Acid; Hemoglobins; Humans; Iron; Maltose; Postnatal Care; Postpartum Period; Pregnancy; Tanzania; Treatment Outcome; Young Adult	2021
Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study. European journal of heart failure, 2021, Volume: 23, Issue:4 Topics: Anemia, Iron-Deficiency; Exercise Tolerance; Ferric Compounds; Heart Failure; Humans; Iron; Maltose; Quality of Life; Stroke Volume; Treatment Outcome	2021
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm study. Internal medicine journal, 2021, Volume: 51, Issue:8 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Iron; Maltose	2021
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis. Nutrients, 2021, Feb-12, Volume: 13, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Colitis, Ulcerative; Comparative Effectiveness Research; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Hematinics; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Treatment Outcome	2021
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial. Inflammatory bowel diseases, 2022, 03-02, Volume: 28, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Treatment Outcome	2022
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, 2021, 08-17, Volume: 42, Issue:31 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose; Quality of Life; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2021
Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia. Sleep medicine, 2021, Volume: 84 Topics: Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Humans; Maltose; Restless Legs Syndrome; Treatment Outcome	2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency. BMJ open, 2021, 08-09, Volume: 11, Issue:8 Topics: Anemia, Iron-Deficiency; Atrial Fibrillation; Australia; Double-Blind Method; Ferric Compounds; Humans; Iron; Maltose	2021
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, Sep-01, Volume: 32, Issue:9 Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Glomerular Filtration Rate; Humans; Iron; Male; Maltose; Prospective Studies; Renal Insufficiency, Chronic; Time Factors	2017
Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials. BMC women's health, 2018, 01-05, Volume: 18, Issue:1 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Hematinics; Hemoglobins; Humans; Maltose; Pregnancy; Pregnancy Complications; Treatment Outcome; Young Adult	2018
Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC heart failure, 2018, Volume: 5, Issue:2 Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Humans; Injections, Intravenous; Iron; Male; Maltose; Middle Aged; Pilot Projects; Prevalence; Retrospective Studies; Singapore; Stroke Volume; Time Factors; Treatment Outcome	2018
Safety and Efficacy of Intravenous Ferric Carboxy Maltose in Iron Deficiency Anaemia During Post-partum Period. Journal of Nepal Health Research Council, 2018, Jan-01, Volume: 15, Issue:3 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Maltose; Nepal; Postpartum Period; Young Adult	2018
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial. American journal of hematology, 2018, Volume: 93, Issue:5 Topics: Adult; Aged; Anemia, Iron-Deficiency; Drug Hypersensitivity; Female; Ferric Compounds; Ferrosoferric Oxide; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Treatment Outcome	2018
Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design. Clinical cardiology, 2018, Volume: 41, Issue:6 Topics: Aged; Anemia, Iron-Deficiency; Clinical Protocols; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Maltose; Myocardium; Quality of Life; Recovery of Function; Research Design; Severity of Illness Index; Spain; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2018
High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. Journal of the American College of Cardiology, 2018, 05-15, Volume: 71, Issue:19 Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Ferric Compounds; Heart Failure; Humans; Hypophosphatemia; Infusions, Intravenous; Maltose; Pilot Projects; Prospective Studies; Stroke Volume	2018
Cost-effectiveness analysis of ferric carboxymaltose in pre-operative haemoglobin optimisation in patients undergoing primary knee arthroplasty. Blood transfusion = Trasfusione del sangue, 2018, Volume: 16, Issue:5 Topics: Anemia, Iron-Deficiency; Arthroplasty, Replacement, Knee; Costs and Cost Analysis; Decision Making; Erythrocyte Transfusion; Female; Ferric Compounds; Humans; Male; Maltose; Preoperative Care	2018
Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study. International journal of hematology, 2019, Volume: 109, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Japan; Maltose; Menorrhagia; Middle Aged; Treatment Outcome; Young Adult	2019
Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron. Digestive diseases and sciences, 2018, Volume: 63, Issue:11 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Gastrointestinal Diseases; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies	2018
Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study. International journal of hematology, 2019, Volume: 109, Issue:1 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Hemoglobins; Japan; Maltose; Treatment Outcome	2019
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Seminars in hematology, 2018, Volume: 55, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Humans; Infusions, Intravenous; Maltose; Middle Aged; Pregnancy; Prospective Studies; Young Adult	2018
Randomized trial of intravenous iron-induced hypophosphatemia. JCI insight, 2018, 12-06, Volume: 3, Issue:23 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Calcitriol; Calcium; Female; Ferric Compounds; Ferrosoferric Oxide; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Hyperparathyroidism; Hypophosphatemia; Iron; Male; Maltose; Middle Aged; Phosphates; Risk Factors	2018
Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC pregnancy and childbirth, 2019, Feb-04, Volume: 19, Issue:1 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Erythrocyte Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hematinics; Hemoglobins; Humans; India; Iron; Maltose; Pregnancy; Pregnancy Complications; Prenatal Care; Treatment Outcome; Young Adult	2019
Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study. The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:4 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hematinics; Hemoglobins; Humans; Maltose; Menorrhagia; Middle Aged; Outcome Assessment, Health Care; Young Adult	2019
High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. Clinical nutrition (Edinburgh, Scotland), 2020, Volume: 39, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Blood Donors; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Follow-Up Studies; Humans; Male; Maltose; Middle Aged; Prospective Studies; Transferrin; Young Adult	2020
Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet (London, England), 2019, 06-01, Volume: 393, Issue:10187 Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Folic Acid; Heart Diseases; Humans; Male; Maltose; Middle Aged; Preoperative Care; Prospective Studies; Time Factors; Vitamin B 12	2019
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2013, Volume: 28, Issue:8 Topics: Adult; Anemia, Iron-Deficiency; Animals; Calcium; Demography; Erythropoiesis; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Iron; Iron-Dextran Complex; Maltose; Mice; Models, Biological; Parathyroid Hormone; Phosphates; Vitamin D	2013
The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. European journal of heart failure, 2013, Volume: 15, Issue:7 Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Double-Blind Method; Erythrocyte Indices; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Prospective Studies; Treatment Outcome	2013
Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflammatory bowel diseases, 2013, Volume: 19, Issue:8 Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Hepcidins; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Male; Maltose; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Count; Prognosis; Prospective Studies; Thrombocytosis; Young Adult	2013
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion, 2014, Volume: 54, Issue:2 Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Heart Diseases; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Maltose; Middle Aged; Risk Factors; Stroke; Treatment Outcome	2014
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European journal of heart failure, 2013, Volume: 15, Issue:11 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Case-Control Studies; Chronic Disease; Deficiency Diseases; Female; Ferric Compounds; Heart Failure; Hematinics; Humans; Iron Deficiencies; Male; Maltose; Middle Aged; Quality of Life; Treatment Outcome	2013
Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis. International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4 Topics: Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Humans; Internationality; Male; Maltose; Middle Aged; Quality of Life; Retrospective Studies; Treatment Outcome	2013
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:4 Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome	2014
The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:4 Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Maltose; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome	2014
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:11 Topics: Administration, Oral; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferritins; Follow-Up Studies; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Maltose; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome	2014
Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anemia; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; Hemoglobins; Humans; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Maltose; Middle Aged; Multiple Myeloma; Treatment Outcome	2014
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. European journal of heart failure, 2015, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kidney; Male; Maltose; Middle Aged; Renal Insufficiency	2015
Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients. BMC surgery, 2015, Jun-28, Volume: 15 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Clinical Protocols; Colorectal Neoplasms; Dietary Supplements; Female; Ferric Compounds; Ferrous Compounds; Fumarates; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Preoperative Care; Treatment Outcome; Young Adult	2015
The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Annals of surgery, 2016, Volume: 264, Issue:1 Topics: Abdominal Cavity; Aged; Anemia, Iron-Deficiency; Blood Loss, Surgical; Blood Transfusion; Body Mass Index; Digestive System Surgical Procedures; Female; Ferric Compounds; Follow-Up Studies; Humans; Injections, Intravenous; Length of Stay; Male; Maltose; Middle Aged; Perioperative Care; Postoperative Care; Quality of Life; Treatment Outcome	2016
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 133, Issue:1 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; India; Maltose; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Hemorrhage	2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. PloS one, 2016, Volume: 11, Issue:6 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hepcidins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Time Factors	2016
Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). Journal of perinatal medicine, 2017, May-24, Volume: 45, Issue:4 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Humans; Infant, Newborn; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Quality of Life; Treatment Outcome	2017
Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. The Lancet. Haematology, 2016, Volume: 3, Issue:9 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Elective Surgical Procedures; Female; Ferric Compounds; Follow-Up Studies; Hemoglobins; Humans; Male; Maltose; Middle Aged; Postoperative Complications; Prognosis; Standard of Care	2016
Praxis, 2016, Volume: 105, Issue:24 Topics: Adult; Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferritins; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Postoperative Complications; Prospective Studies	2016
Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer. The British journal of surgery, 2017, Volume: 104, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Colorectal Neoplasms; Elective Surgical Procedures; Erythrocyte Transfusion; Female; Ferric Compounds; Ferrous Compounds; Follow-Up Studies; Hematinics; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Postoperative Complications; Preoperative Care; Prospective Studies; Treatment Outcome	2017
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4 Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Injections; Maltose; Puerperal Disorders; Treatment Outcome	2008
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion, 2009, Volume: 49, Issue:12 Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Calcium; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Maltose; Middle Aged; Phosphates; Potassium; Quality of Life; Treatment Outcome; Uterine Hemorrhage	2009
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. European journal of heart failure, 2009, Volume: 11, Issue:11 Topics: Algorithms; Anemia, Iron-Deficiency; Chronic Disease; Clinical Protocols; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Humans; Injections, Intravenous; Male; Maltose; Patient Care; Reference Values; Research Design; Treatment Outcome	2009
Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodialysis international. International Symposium on Home Hemodialysis, 2010, Volume: 14, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Cross-Over Studies; Double-Blind Method; Female; Ferric Compounds; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Maltose; Middle Aged; Treatment Outcome	2010
Ferric carboxymaltose in patients with heart failure and iron deficiency. The New England journal of medicine, 2009, Dec-17, Volume: 361, Issue:25 Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Female; Ferric Compounds; Ferritins; Follow-Up Studies; Heart Failure; Hematinics; Humans; Iron Deficiencies; Male; Maltose; Quality of Life; Stroke Volume; Ventricular Dysfunction, Left	2009
The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:8 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Maltose; Middle Aged; Renal Dialysis; Treatment Outcome; Young Adult	2010
Iron in heart failure: friend or foe? Current heart failure reports, 2010, Volume: 7, Issue:2 Topics: Anemia, Iron-Deficiency; Biomarkers; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Hemoglobins; Humans; Iron; Male; Maltose; Treatment Outcome	2010
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hemoglobins; Humans; Kidney Diseases; Male; Maltose; Middle Aged; Risk Factors; Sucrose; Treatment Outcome	2010
Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. Arzneimittel-Forschung, 2010, Volume: 60, Issue:6a Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Pressure; Body Temperature; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Ferric Compounds; Heart Rate; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged	2010
Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder. Arzneimittel-Forschung, 2010, Volume: 60, Issue:6a Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Hemoglobins; Humans; Male; Maltose; Middle Aged; Patient Selection; Transferrin	2010
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:5 Topics: Administration, Oral; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Maltose; Prognosis	2011
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology, 2011, Volume: 141, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Comorbidity; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome; Young Adult	2011
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. European heart journal, 2013, Volume: 34, Issue:1 Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Double-Blind Method; Ferric Compounds; Heart Failure; Hematinics; Homeostasis; Humans; Injections, Intravenous; Iron Deficiencies; Maltose; Quality of Life; Treatment Outcome; Ventricular Dysfunction, Left	2013
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:3 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Middle Aged; Placebos; Secondary Prevention; Single-Blind Method; Treatment Outcome; Young Adult	2013
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Follow-Up Studies; Humans; Injections, Intravenous; Iron; Male; Maltose; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult	2013
Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. American journal of hematology, 2013, Volume: 88, Issue:2 Topics: Adult; Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Biomarkers; Dietary Supplements; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Hepcidins; Humans; Injections, Intravenous; Iron, Dietary; Male; Maltose; Predictive Value of Tests; Sensitivity and Specificity; Transferrin	2013
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations. Atherosclerosis. Supplements, 2013, Volume: 14, Issue:1 Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Blood Component Removal; Chemistry, Pharmaceutical; Drug Administration Schedule; Dyslipidemias; Female; Ferric Compounds; Ferritins; Germany; Hematinics; Humans; Infusions, Intravenous; Lipoproteins; Male; Maltose; Middle Aged; Time Factors; Transferrin; Treatment Outcome	2013
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 101, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Maltose; Postpartum Period; Time Factors; Treatment Outcome	2008
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. The American journal of gastroenterology, 2008, Volume: 103, Issue:5 Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Germany; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged	2008

Other Studies

170 other study(ies) available for acebutolol and Anemia, Iron-Deficiency

Article	Year
Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry. European journal of heart failure, 2021, Volume: 23, Issue:11 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Iron Deficiencies; Maltose; Quality of Life; Registries; Stroke Volume; Sweden	2021
A budget impact analysis of iron polymaltose and ferric carboxymaltose infusions. International journal of clinical pharmacy, 2022, Volume: 44, Issue:1 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Infusions, Intravenous; Maltose	2022
Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long-term study. Journal of cachexia, sarcopenia and muscle, 2021, Volume: 12, Issue:6 Topics: Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Iron Deficiencies; Male; Maltose; Middle Aged; Pulmonary Arterial Hypertension; Retrospective Studies	2021
In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk. Annals of internal medicine, 2021, Volume: 174, Issue:10 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Maltose; Quality of Life	2021
Iron deficiency testing and treatment in heart failure: the eyes are useless when the mind is blind. European journal of heart failure, 2021, Volume: 23, Issue:11 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Hospitalization; Humans; Iron Deficiencies; Maltose; Transferrin	2021
Impact of in-hospital intravenous iron supplementation on red blood cell transfusions: experience from an Internal Medicine Unit. Blood transfusion = Trasfusione del sangue, 2021, Volume: 19, Issue:6 Topics: Aftercare; Anemia, Iron-Deficiency; Dietary Supplements; Erythrocyte Transfusion; Ferric Compounds; Hospitals; Humans; Iron; Iron Deficiencies; Maltose; Patient Discharge; Retrospective Studies	2021
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose. The Journal of clinical endocrinology and metabolism, 2022, 03-24, Volume: 107, Issue:4 Topics: Alkaline Phosphatase; Anemia, Iron-Deficiency; Biomarkers; Calcium; Disaccharides; Familial Hypophosphatemic Rickets; Female; Ferric Compounds; Humans; Hypophosphatemia; Iron; Male; Maltose; Minerals; Osteomalacia; Parathyroid Hormone; Risk Factors	2022
Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experience. European journal of gastroenterology & hepatology, 2022, 06-01, Volume: 34, Issue:6 Topics: Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Retrospective Studies; Treatment Outcome	2022
Does Postoperative Intravenous Ferric Carboxymaltose Hasten the Recovery of Hemoglobin in Patients Post Total Knee Arthroplasty? The Journal of arthroplasty, 2022, Volume: 37, Issue:6S Topics: Anemia, Iron-Deficiency; Arthroplasty, Replacement, Knee; Ferric Compounds; Hemoglobins; Humans; Iron; Maltose; Retrospective Studies	2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. European journal of heart failure, 2022, Volume: 24, Issue:5 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Iron Deficiencies; Maltose; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Walk Test	2022
Analysis of transition from intravenous iron sucrose to ferric carboxymaltose infusions in pediatric patients with intestinal failure. JPEN. Journal of parenteral and enteral nutrition, 2022, Volume: 46, Issue:7 Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Ferric Oxide, Saccharated; Humans; Infusions, Intravenous; Intestinal Failure; Iron; Maltose	2022
Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience. European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:10 Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Iron; Maltose; Menorrhagia; Transferrins	2022
Potential role of empagliflozin in myocardial iron repletion following ferric carboxymaltose for heart failure. Revista espanola de cardiologia (English ed.), 2023, Volume: 76, Issue:2 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose	2023
[A case of chronic enteropathy associated with SLCO2A1 gene diagnosed by capsule endoscopy and successfully treated by ferric carboxymaltose]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2022, Volume: 119, Issue:7 Topics: Anemia; Anemia, Iron-Deficiency; Capsule Endoscopy; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Middle Aged; Organic Anion Transporters; Ulcer	2022
Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study. International journal of hematology, 2022, Volume: 116, Issue:6 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Gastrointestinal Diseases; Hemoglobins; Humans; Maltose	2022
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial. European journal of heart failure, 2022, Volume: 24, Issue:10 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron Deficiencies; Male; Maltose; Quality of Life	2022
Efficacy of high-dose intravenous iron in middle-aged to elderly iron-deficient patients. The Medical journal of Malaysia, 2022, Volume: 77, Issue:5 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Maltose; Middle Aged	2022
Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK. Scientific reports, 2022, 11-07, Volume: 12, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Iron; Male; Maltose; Pregnancy; Retrospective Studies; United Kingdom	2022
Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals. Scientific reports, 2022, 11-11, Volume: 12, Issue:1 Topics: Adult; Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Hemoglobins; Hospitals; Humans; Iron; Maltose; Portugal; Retrospective Studies; State Medicine	2022
Increases in Fibroblast Growth Factor 23 During Treatment With Ferric Carboxymaltose: Potential Adverse Effects on the Heart and Kidneys. Journal of cardiac failure, 2023, Volume: 29, Issue:2 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Fibroblast Growth Factor-23; Heart Failure; Humans; Kidney; Maltose	2023
Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose. European journal of internal medicine, 2023, Volume: 110 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Humans; Maltose	2023
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation. European journal of heart failure, 2023, Volume: 25, Issue:3 Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Ferric Compounds; Heart Failure; Hospitalization; Humans; Iron Deficiencies; Maltose; Patient Discharge; Quality of Life; Stroke Volume; Ventricular Function, Left	2023
Ferric Carboxymaltose-mediated Methemoglobinemia. Current drug safety, 2024, Volume: 19, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Maltose; Methemoglobin; Methemoglobinemia	2024
Intravenous ferric derisomaltose for patients with heart failure: does iron heart translate into IRONMAN? European heart journal, 2023, 04-07, Volume: 44, Issue:14 Topics: Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Heart Failure; Humans; Iron; Maltose	2023
In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death. Annals of internal medicine, 2023, Volume: 176, Issue:4 Topics: Anemia, Iron-Deficiency; Heart Failure; Hospitalization; Humans; Iron Deficiencies; Maltose; Prospective Studies	2023
What is wrong in doing good? British journal of haematology, 2023, Volume: 202, Issue:6 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Hypophosphatemia; Iron; Maltose	2023
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy. Advances in therapy, 2019, Volume: 36, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Female; Ferric Compounds; Hematinics; Humans; Italy; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies	2019
Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost-effectiveness and budget impact. Journal of comparative effectiveness research, 2019, Volume: 8, Issue:13 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Budgets; Chronic Disease; Cost-Benefit Analysis; Ferric Compounds; Heart Failure; Humans; Italy; Maltose; Markov Chains; Models, Econometric	2019
Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department. Internal and emergency medicine, 2020, Volume: 15, Issue:4 Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Emergency Service, Hospital; Female; Ferric Compounds; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Retrospective Studies	2020
Letter to the Editor. Journal of paediatrics and child health, 2019, Volume: 55, Issue:12 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Male; Maltose	2019
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Rheumatology (Oxford, England), 2020, 08-01, Volume: 59, Issue:8 Topics: Adult; Anemia, Iron-Deficiency; Antibodies, Monoclonal, Humanized; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Maltose; Osteomalacia; Treatment Outcome	2020
Hypophosphatemia in children treated with ferric carboxymaltose. Acta paediatrica (Oslo, Norway : 1992), 2020, Volume: 109, Issue:7 Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Hypophosphatemia; Maltose	2020
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine. Internal and emergency medicine, 2020, Volume: 15, Issue:4 Topics: Anemia, Iron-Deficiency; Blood Transfusion; Emergency Medicine; Emergency Service, Hospital; Ferric Compounds; Humans; Maltose	2020
Development of a Resource Impact Model for Clinics Treating Pre-Operative Iron Deficiency Anemia in Ireland. Advances in therapy, 2020, Volume: 37, Issue:3 Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Costs and Cost Analysis; Disaccharides; Ferric Compounds; Health Resources; Humans; Ireland; Maltose; Models, Economic; Preoperative Care	2020
Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Mar-03, Volume: 90, Issue:1 Topics: Aged; Anemia, Iron-Deficiency; Cardiac Surgical Procedures; Exercise Tolerance; Female; Ferric Compounds; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Retrospective Studies; Treatment Outcome	2020
Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2020, Volume: 24, Issue:6 Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Clinical Protocols; Costs and Cost Analysis; Erythropoietin; Female; Ferric Compounds; Ferritins; Hematinics; Humans; Iron; Italy; Male; Maltose; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome	2020
Desensitization in Iron Product Allergy. Acta haematologica, 2020, Volume: 143, Issue:5 Topics: Adult; Anemia, Iron-Deficiency; Chlorpheniramine; Dexamethasone; Female; Ferric Compounds; Hematinics; Humans; Hypersensitivity; Iron; Maltose; Middle Aged; Skin Tests	2020
High Risk of Hypophosphatemia in Patients with Previous Bariatric Surgery Receiving Ferric Carboxymaltose: A Prospective Cohort Study. Obesity surgery, 2020, Volume: 30, Issue:7 Topics: Adult; Aged; Anemia, Iron-Deficiency; Bariatric Surgery; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Maltose; Middle Aged; Obesity, Morbid; Prospective Studies; Young Adult	2020
Case report: A rare cause of severe hypophosphatemia. Annales d'endocrinologie, 2020, Volume: 81, Issue:2-3 Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Hypophosphatemia; Infusions, Intravenous; Maltose; Middle Aged; Phosphates; Severity of Illness Index; Vitamin D Deficiency	2020
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status. BMC gastroenterology, 2020, Jun-10, Volume: 20, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Male; Maltose; Middle Aged; Nutritional Status; Phosphates; Prospective Studies; Risk Factors; Treatment Outcome; Vitamin D; Young Adult	2020
Iron deficiency and safety of ferric carboxymaltose in patients with acute heart failure. AHF-ID study. International journal of clinical practice, 2020, Volume: 74, Issue:10 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Heart Failure; Humans; Male; Maltose; Middle Aged; Prospective Studies; Treatment Outcome	2020
Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia. Transfusion, 2020, Volume: 60, Issue:7 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Outpatients; Retrospective Studies; Severity of Illness Index	2020
Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents. Pediatric blood & cancer, 2020, Volume: 67, Issue:10 Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Follow-Up Studies; Humans; Infant; Iron Metabolism Disorders; Male; Maltose; Prognosis; Retrospective Studies	2020
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency. Bone, 2020, Volume: 141 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Maltose; Minerals	2020
Fatal anaphylactic reaction due to ferric carboxymaltose: A case report. Anatolian journal of cardiology, 2020, Volume: 24, Issue:2 Topics: Aged; Anaphylaxis; Anemia, Iron-Deficiency; Fatal Outcome; Ferric Compounds; Humans; Male; Maltose	2020
The Impact of the Ferric Carboxymaltose on Hemoglobin and Ferritin Levels. Clinical laboratory, 2020, Aug-01, Volume: 66, Issue:8 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Hemoglobins; Humans; Maltose	2020
Comparison between oral ferrous sulfate and intravenous ferric carboxymaltose in children with restless sleep disorder. Sleep, 2021, 02-12, Volume: 44, Issue:2 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Ferric Compounds; Ferrous Compounds; Humans; Maltose; Pilot Projects; Retrospective Studies; Sleep Wake Disorders	2021
Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects. Internal and emergency medicine, 2021, Volume: 16, Issue:2 Topics: Administration, Intravenous; Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Maltose; Thrombasthenia	2021
Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome. Sleep medicine, 2020, Volume: 75 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Maltose; Restless Legs Syndrome; Retrospective Studies; Treatment Outcome	2020
Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h. European journal of clinical pharmacology, 2021, Volume: 77, Issue:2 Topics: Administration, Oral; Anemia, Iron-Deficiency; Cost Savings; Cost-Benefit Analysis; Decision Support Systems, Clinical; Drug Prescriptions; Ferric Compounds; Ferric Oxide, Saccharated; France; Health Plan Implementation; Hematinics; Hospital Costs; Hospitalization; Humans; Infusions, Intravenous; Interrupted Time Series Analysis; Iron; Maltose; Pharmacy Service, Hospital; Program Evaluation; Treatment Outcome	2021
Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents. Pediatric blood & cancer, 2021, Volume: 68, Issue:3 Topics: Administration, Intravenous; Adolescent; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Iron; Maltose; Risk Assessment	2021
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain. Journal of medical economics, 2020, Volume: 23, Issue:12 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose; Prospective Studies; Quality of Life; Spain; Stroke Volume; Ventricular Function, Left	2020
Ferric Carboxymaltose Across All Ages in Paediatric Gastroenterology Shows Efficacy Without Increased Safety Concerns. Journal of pediatric gastroenterology and nutrition, 2021, 04-01, Volume: 72, Issue:4 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Ferric Compounds; Gastroenterology; Humans; Infusions, Intravenous; Male; Maltose; Retrospective Studies	2021
Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert review of hematology, 2022, Volume: 15, Issue:4 Topics: Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Humans; Iron Deficiencies; Maltose	2022
Iron heart. European heart journal, 2021, 02-21, Volume: 42, Issue:8 Topics: Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Heart Failure; Humans; Iron; Maltose; Patient Discharge	2021
Phosphorus levels in children treated with intravenous ferric carboxymaltose. American journal of hematology, 2021, 06-01, Volume: 96, Issue:6 Topics: Adolescent; Age Factors; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Humans; Hypophosphatemia; Infant; Infusions, Intravenous; Male; Maltose; Phosphorus; Retrospective Studies; Young Adult	2021
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:7 Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Hypophosphatemia; Inflammatory Bowel Diseases; Iron; Male; Maltose; Phosphates; Prevalence; Risk Factors; Severity of Illness Index; Treatment Outcome	2021
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y. Annals of internal medicine, 2021, Volume: 174, Issue:4 Topics: Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Heart Failure; Hospitalization; Humans; Maltose; Patient Discharge	2021
Attitude changes in prescribing intravenous iron supplementation in different settings at a hospital consortium in Italy. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021, Volume: 60, Issue:4 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Costs and Cost Analysis; Drug Prescriptions; Female; Ferric Compounds; Ferrous Compounds; Humans; Male; Maltose	2021
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design. Circulation. Heart failure, 2021, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Heart Failure; Humans; Male; Maltose; Middle Aged; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left	2021
Intravenous iron is non-inferior to oral iron regarding cell growth and iron metabolism in colorectal cancer associated with iron-deficiency anaemia. Scientific reports, 2021, 07-01, Volume: 11, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cell Proliferation; Colorectal Neoplasms; Female; Ferric Compounds; Ferrous Compounds; Humans; Iron; Male; Maltose; Middle Aged	2021
Clinical effects and safety of ferric carboxymaltose in pregnancy: An Indian real-life experience. The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:10 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Infant, Newborn; Maltose; Pregnancy; Retrospective Studies; Treatment Outcome	2021
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia. PloS one, 2021, Volume: 16, Issue:8 Topics: Administration, Intravenous; Adult; Aged; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Health Expenditures; Humans; Male; Maltose; Middle Aged; Treatment Outcome; Young Adult	2021
[Iron deficiency : a new target in treating chronic heart failure ?] Revue medicale suisse, 2016, Oct-19, Volume: 12, Issue:535 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Heart Failure; Hospitalization; Humans; Iron Deficiencies; Maltose; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic	2016
Iron substitution in the treatment of chronic heart failure. Swiss medical weekly, 2017, Volume: 147 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Chronic Disease; Comorbidity; Ferric Compounds; Heart Failure; Hospitalization; Humans; Iron Deficiencies; Maltose; Prognosis; Randomized Controlled Trials as Topic	2017
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients. BioMed research international, 2017, Volume: 2017 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Hemoglobins; Hospitals; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron; Italy; Maltose; Technology Assessment, Biomedical; Treatment Outcome	2017
Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre. European journal of pediatrics, 2017, Volume: 176, Issue:10 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Hematinics; Humans; Infant; Infusions, Intravenous; Male; Maltose; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; United Kingdom	2017
Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Archives of gynecology and obstetrics, 2017, Volume: 296, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Humans; Iron; Maltose; Postpartum Period; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Severity of Illness Index; Treatment Outcome	2017
Ferric Carboxymaltose to Treat Isovolemic Anemia. JAMA, 2017, 10-03, Volume: 318, Issue:13 Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Maltose	2017
Ferric Carboxymaltose to Treat Isovolemic Anemia-Reply. JAMA, 2017, 10-03, Volume: 318, Issue:13 Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Maltose	2017
"Pumping Iron" to Improve Exercise Performance in Heart Failure: New Data and New Guidelines. Circulation, 2017, 10-10, Volume: 136, Issue:15 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose	2017
Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia. Journal of Nepal Health Research Council, 2017, Sep-08, Volume: 15, Issue:2 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Maltose; Nepal; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Socioeconomic Factors; Young Adult	2017
Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK. Expert opinion on drug delivery, 2017, Volume: 14, Issue:12 Topics: Anemia, Iron-Deficiency; Budgets; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Retrospective Studies; United Kingdom	2017
Intravenous ferric carboxymaltose for heart failure with iron deficiency. European journal of heart failure, 2018, Volume: 20, Issue:1 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Humans; Iron; Maltose	2018
Safety and efficacy of parenteral iron in children with inflammatory bowel disease. British journal of clinical pharmacology, 2018, Volume: 84, Issue:4 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Infusions, Intravenous; Male; Maltose; Retrospective Studies; Transferrin	2018
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration. BMJ case reports, 2018, Jan-03, Volume: 2018 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Crohn Disease; Diagnosis, Differential; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Osteomalacia; Phosphates; Treatment Outcome	2018
Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with iron-deficiency anemia. International journal of hematology, 2018, Volume: 107, Issue:5 Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Asian People; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Hematopoiesis; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Reticulocyte Count; Safety; Young Adult	2018
Inflammatory bowel disease and anemia: intravenous iron treatment. Scandinavian journal of gastroenterology, 2018, Volume: 53, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Exanthema; Female; Ferric Compounds; Ferritins; Finland; Humans; Inflammatory Bowel Diseases; Iron; Linear Models; Male; Maltose; Middle Aged; Nausea; Receptors, Transferrin; Retrospective Studies; Treatment Outcome; Young Adult	2018
Retrospective cohort study comparing the adverse reactions and efficacy of intravenous iron polymaltose with ferric carboxymaltose for iron deficiency anemia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018, Volume: 141, Issue:3 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Australia; Cohort Studies; Female; Ferric Compounds; Humans; Maltose; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult	2018
Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study. International journal of clinical pharmacy, 2018, Volume: 40, Issue:3 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inpatients; Length of Stay; Male; Maltose; Middle Aged; Retrospective Studies	2018
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Archives of gynecology and obstetrics, 2018, Volume: 298, Issue:1 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Infant, Newborn; Infusions, Intravenous; Iron Deficiencies; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Pregnant Women; Prenatal Care; Prospective Studies; Treatment Outcome	2018
Impact of ferric carboxymaltose on the evolution of hemoglobin and ECOG performance status in iron-deficient patients with solid tumors: a 3-month follow-up retrospective study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Blood Transfusion; Female; Ferric Compounds; Ferritins; Follow-Up Studies; Health Status Indicators; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Quality of Life; Retrospective Studies; Young Adult	2018
Budget Impact Analysis of Oral Fisiogen Ferro Forte Clinical drug investigation, 2018, Volume: 38, Issue:9 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Budgets; Cost Savings; Ferric Compounds; Health Care Costs; Hospitalization; Humans; Iron; Kidney Transplantation; Maltose; Models, Economic; Peritoneal Dialysis; Renal Insufficiency, Chronic; Spain	2018
Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice. Journal of Crohn's & colitis, 2018, Jun-28, Volume: 12, Issue:7 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Male; Maltose; Middle Aged; Prospective Studies; Quality of Life; Severity of Illness Index; Transferrin; Young Adult	2018
A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia. American journal of hematology, 2018, Volume: 93, Issue:9 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferrosoferric Oxide; Humans; Maltose	2018
A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia". American journal of hematology, 2018, Volume: 93, Issue:9 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferrosoferric Oxide; Humans; Maltose	2018
Iron supplementation in a case of severe iron deficiency anaemia. British journal of anaesthesia, 2018, Volume: 121, Issue:2 Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Ferric Compounds; Hemoglobins; Humans; Iron; Male; Maltose	2018
Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women. BMC pregnancy and childbirth, 2018, Aug-28, Volume: 18, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Hemoglobins; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Republic of Korea; Young Adult	2018
Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients. BMC nephrology, 2018, 09-20, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Drug Substitution; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hematinics; Humans; Iron; Longitudinal Studies; Male; Maltose; Middle Aged; Netherlands; Renal Dialysis; Retrospective Studies	2018
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Archives of gynecology and obstetrics, 2018, Volume: 298, Issue:6 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Hemoglobins; Humans; Iron; Maltose; Pregnancy	2018
Response to letter to the Editor: Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Archives of gynecology and obstetrics, 2018, Volume: 298, Issue:6 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Maltose; Pregnancy	2018
Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer British journal of clinical pharmacology, 2019, Volume: 85, Issue:2 Topics: Adult; Aged; Anemia, Iron-Deficiency; Comorbidity; Disaccharides; Drug Hypersensitivity; Female; Ferric Compounds; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Netherlands; Prospective Studies; Risk Factors	2019
An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in therapy, 2018, Volume: 35, Issue:12 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Denmark; Disaccharides; Female; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Maltose; Middle Aged; Retrospective Studies	2018
Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries. Scandinavian cardiovascular journal : SCJ, 2018, Volume: 52, Issue:6 Topics: Aged; Anemia, Iron-Deficiency; Clinical Trials, Phase III as Topic; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Guideline Adherence; Heart Failure; Hematinics; Humans; Male; Maltose; Models, Economic; Practice Guidelines as Topic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Registries; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome	2018
Effectiveness of outpatient treatment with intravenous iron in selected primary Care patients. Medicina clinica, 2020, 01-24, Volume: 154, Issue:2 Topics: Administration, Intravenous; Adult; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Hematinics; Humans; Male; Maltose; Middle Aged	2020
Iron-deficiency anemia reduces cardiac contraction by downregulating RyR2 channels and suppressing SERCA pump activity. JCI insight, 2019, 04-04, Volume: 4, Issue:7 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Animals; Calcium; Calcium-Binding Proteins; Cells, Cultured; Disease Models, Animal; Down-Regulation; Ferric Compounds; Heart Failure; Humans; Iron; Magnetic Resonance Imaging; Male; Maltose; Mice; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Primary Cell Culture; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stroke Volume	2019
[Assessment of iron deficiency anemia management in the general hospital of Grenoble: A 12-month follow-up of an intravenous ferric carboxymaltose treatment program in a cohort of patients with non-dialysis-dependent chronic kidney disease]. Nephrologie & therapeutique, 2019, Volume: 15, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cohort Studies; Female; Ferric Compounds; Follow-Up Studies; Hematinics; Hospitals, General; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Renal Insufficiency, Chronic	2019
Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing. BMC nephrology, 2019, 03-01, Volume: 20, Issue:1 Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Monitoring; Female; Ferric Compounds; Ferritins; Hematinics; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Transferrin	2019
Safety profile of iron polymaltose infusions. Hospital practice (1995), 2019, Volume: 47, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Australia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2019
Extravasation and pigmentation post iron infusion. British journal of hospital medicine (London, England : 2005), 2019, Apr-02, Volume: 80, Issue:4 Topics: Anemia, Iron-Deficiency; Extravasation of Diagnostic and Therapeutic Materials; Female; Ferric Compounds; Humans; Infusions, Intravenous; Maltose; Middle Aged; Pigmentation Disorders	2019
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in therapy, 2019, Volume: 36, Issue:8 Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Denmark; Disaccharides; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Maltose	2019
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in therapy, 2019, Volume: 36, Issue:8 Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Denmark; Disaccharides; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Maltose	2019
Intravenous Iron Use in the Care of Patients with Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN, 2019, 10-07, Volume: 14, Issue:10 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Renal Insufficiency, Chronic	2019
Skin staining following intravenous iron infusion. BMJ case reports, 2019, Jun-06, Volume: 12, Issue:6 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Infusions, Intravenous; Maltose; Pregnancy; Pregnancy Trimester, First; Skin Pigmentation	2019
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:4 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Disaccharides; Female; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Inflammatory Bowel Diseases; Male; Maltose; Middle Aged; Norway; Prospective Studies; Quality of Life; Risk Factors	2019
Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients. Obesity surgery, 2013, Volume: 23, Issue:9 Topics: Adult; Anemia, Iron-Deficiency; Bariatric Surgery; Biomarkers; Dietary Supplements; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron, Dietary; Malabsorption Syndromes; Male; Maltose; Middle Aged; Obesity, Morbid; Parenteral Nutrition; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Transferrin; Treatment Outcome; United States	2013
The effect of intravenous antibiotics on anaemia in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:6 Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose	2013
Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Volume: 33, Issue:3 Topics: Aged; Anemia, Iron-Deficiency; Cell Adhesion Molecules; Female; Ferric Compounds; Humans; Inflammation; Kidney Failure, Chronic; Male; Maltose; Prospective Studies	2013
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10 Topics: Anemia, Iron-Deficiency; Central Venous Catheters; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Infusions, Intravenous; Maltose; Neoplasms; Practice Patterns, Physicians'; Surveys and Questionnaires	2013
Monitoring iron therapy in chronic heart failure. European journal of heart failure, 2013, Volume: 15, Issue:7 Topics: Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Heart Failure; Hemoglobins; Humans; Male; Maltose	2013
Hemoglobin ≤ 12.9 g/dl predicts risk of antibiotic treatment in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014, Volume: 13, Issue:1 Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose	2014
[Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2013, Volume: 107, Issue:4-5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Child; Child, Preschool; Cost Savings; Cross-Sectional Studies; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Iron Compounds; Male; Maltose; Middle Aged; National Health Programs; Off-Label Use; Retrospective Studies; Switzerland; Young Adult	2013
Ferric carboxymaltose approved for iron deficiency anemia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Sep-01, Volume: 70, Issue:17 Topics: Anemia, Iron-Deficiency; Drug Approval; Ferric Compounds; Humans; Infusions, Intravenous; Maltose	2013
Iron deficiency generates secondary thrombocytosis and platelet activation in inflammatory bowel disease : the randomized, controlled ThromboVIT trial. Inflammatory bowel diseases, 2013, Volume: 19, Issue:11 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Platelet Activation; Thrombocytosis	2013
Reply to Zuo et al. Inflammatory bowel diseases, 2013, Volume: 19, Issue:11 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Platelet Activation; Thrombocytosis	2013
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data. The European journal of health economics : HEPAC : health economics in prevention and care, 2014, Volume: 15, Issue:9 Topics: Anemia, Iron-Deficiency; Budgets; Cost Savings; Drug Substitution; Female; Ferric Compounds; Ferric Oxide, Saccharated; Financing, Personal; Glucaric Acid; Humans; Maltose; National Health Programs; Switzerland	2014
Ferric carboxymaltose (Injectafer) for iron deficiency anemia. The Medical letter on drugs and therapeutics, 2013, Dec-09, Volume: 55, Issue:1431 Topics: Adult; Anemia, Iron-Deficiency; Drug Approval; Ferric Compounds; Humans; Infusions, Intravenous; Maltose; United States; United States Food and Drug Administration	2013
[Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron]. Medicina clinica, 2014, Sep-15, Volume: 143, Issue:6 Topics: Aged; Anemia, Iron-Deficiency; Causality; Diabetes Mellitus, Type 2; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hepatitis C, Chronic; Humans; Hypocalcemia; Hypophosphatemia; Infusions, Intravenous; Male; Maltose	2014
Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient. European journal of clinical nutrition, 2014, Volume: 68, Issue:4 Topics: Administration, Oral; Anemia, Iron-Deficiency; Anorexia; Bulimia; Dietary Supplements; Female; Ferric Compounds; Humans; Hypophosphatemia; Injections, Intravenous; Malnutrition; Maltose; Parenteral Nutrition; Phosphates; Weight Loss; Young Adult	2014
Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC pregnancy and childbirth, 2014, Mar-25, Volume: 14 Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Follow-Up Studies; Gestational Age; Hemoglobins; Humans; Infant, Newborn; Infusions, Intravenous; Iron; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prospective Studies; Treatment Outcome	2014
Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients. Clinical nephrology, 2014, Volume: 81, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Drug Administration Schedule; Erythrocytes; Erythropoiesis; Female; Ferric Compounds; Glutathione Peroxidase; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Multivariate Analysis; Odds Ratio; Oxidative Stress; Predictive Value of Tests; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome	2014
[Iron deficiency anemia and anemia of chronic disease (ACD)]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:22 Topics: Adult; Anemia, Iron-Deficiency; Chronic Disease; Diagnosis, Differential; Erythrocyte Indices; Female; Ferric Compounds; Ferritins; Hemoglobinometry; Humans; Infusions, Intravenous; Iron Deficiencies; Maltose; Menorrhagia; Transferrin	2014
Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. International journal of cardiology, 2014, Aug-01, Volume: 175, Issue:2 Topics: Aged; Anemia, Iron-Deficiency; Exercise Test; Female; Ferric Compounds; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Maltose; Middle Aged; Pilot Projects; Prospective Studies; Quality of Life	2014
Anaemia: FIND-CKD: intravenous iron in predialysis CKD. Nature reviews. Nephrology, 2014, Volume: 10, Issue:9 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Humans; Iron; Male; Maltose; Renal Insufficiency, Chronic	2014
Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC gastroenterology, 2014, Oct-17, Volume: 14 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Retrospective Studies; Treatment Outcome	2014
[Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies]. MMW Fortschritte der Medizin, 2014, Jul-24, Volume: 156 Suppl 2 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Chronic Disease; Dose-Response Relationship, Drug; Female; Ferric Compounds; Follow-Up Studies; Germany; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Transferrin	2014
[What is essential in diagnosis?]. MMW Fortschritte der Medizin, 2014, Jun-26, Volume: 156, Issue:12 Topics: Anemia, Iron-Deficiency; Bone Marrow Examination; Diagnosis, Differential; Early Diagnosis; Ferric Compounds; Ferritins; Hemoglobinometry; Humans; Maltose; Predictive Value of Tests	2014
Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia. Digestive diseases and sciences, 2015, Volume: 60, Issue:5 Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Crohn Disease; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Inflammation Mediators; Interleukin-6; Maltose; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Treatment Outcome	2015
[Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect]. Medicina clinica, 2015, Aug-07, Volume: 145, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hematinics; Humans; Hypophosphatemia; Infusions, Intravenous; Logistic Models; Male; Maltose; Middle Aged; Retrospective Studies; Treatment Outcome	2015
A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain. Revista espanola de cardiologia (English ed.), 2015, Volume: 68, Issue:10 Topics: Aged; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Humans; Incidence; Male; Maltose; Spain	2015
Spontaneous bacterial peritonitis in a patient with anorexia nervosa with profound zinc and iron deficiency. The American journal of medicine, 2015, Volume: 128, Issue:8 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anemia, Iron-Deficiency; Anorexia Nervosa; Escherichia coli Infections; Female; Ferric Compounds; Humans; Maltose; Peritonitis; Zinc	2015
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; France; Hematinics; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Young Adult	2016
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. Atherosclerosis. Supplements, 2015, Volume: 18 Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Blood Component Removal; Drug Administration Schedule; Female; Ferric Compounds; Ferritins; Germany; Hematinics; Humans; Hyperlipoproteinemias; Infusions, Intravenous; Iron; Lipoproteins, LDL; Male; Maltose; Middle Aged; Prospective Studies; Time Factors; Transferrin; Treatment Outcome	2015
Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study. PloS one, 2015, Volume: 10, Issue:5 Topics: Adult; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Ferric Compounds; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Infusions, Intravenous; Male; Maltose; Middle Aged; Patient Compliance; Pilot Projects; Prospective Studies; Treatment Outcome	2015
Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction. International journal of cardiology, 2016, Jan-01, Volume: 202 Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Prognosis; Treatment Outcome; Ventricular Dysfunction, Left	2016
Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technology and health care : official journal of the European Society for Engineering and Medicine, 2016, Volume: 24, Issue:1 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cohort Studies; Colonic Neoplasms; Costs and Cost Analysis; Female; Ferric Compounds; Humans; Iron; Male; Maltose; Middle Aged; Monte Carlo Method; Preoperative Care; Retrospective Studies; Sucrose	2016
Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome. Sleep medicine, 2015, Volume: 16, Issue:11 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferritins; Humans; Maltose; Pilot Projects; Pregnancy; Pregnancy Complications; Prospective Studies; Restless Legs Syndrome; Switzerland; Time Factors; Treatment Outcome	2015
A Safe and Novel Desensitization Protocol with Ferric Carboxymaltose to Treat Iron Deficiency Anemia. Current drug safety, 2016, Volume: 11, Issue:2 Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Humans; Infusions, Intravenous; Maltose; Middle Aged; Treatment Outcome	2016
TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose. Arquivos de gastroenterologia, 2015, Volume: 52, Issue:4 Topics: Adult; Aged; Anemia, Iron-Deficiency; Crohn Disease; Female; Ferric Compounds; Humans; Male; Maltose; Middle Aged; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome; Young Adult	2015
High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood transfusion = Trasfusione del sangue, 2016, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Middle Aged; Prospective Studies; Quality of Life; Young Adult	2016
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:11 Topics: Anemia, Iron-Deficiency; Case-Control Studies; Cell Differentiation; Dendritic Cells; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Macrophages; Maltose; MicroRNAs; Monocytes; Phagocytosis	2016
[Iron deficiency therapy: focus is on the patient]. MMW Fortschritte der Medizin, 2016, May-25, Volume: 158, Issue:10 Topics: Anemia, Iron-Deficiency; Ferric Compounds; General Practice; Humans; Infusions, Intravenous; Maltose; Prospective Studies; Quality of Life	2016
Iron and vitamin D deficiency in inflammatory bowel disease. Journal of gastroenterology and hepatology, 2016, Volume: 31 Suppl 1 Topics: Administration, Oral; Anemia, Iron-Deficiency; Cholecalciferol; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Injections, Intramuscular; Maltose; Vitamin D Deficiency	2016
Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose. Blood cells, molecules & diseases, 2016, Volume: 59 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dialysis; Drug Monitoring; Erythropoiesis; Female; Ferric Compounds; Hepcidins; Humans; Male; Maltose; Middle Aged; Prognosis; Prospective Studies; Receptors, Transferrin; Renal Insufficiency, Chronic; Sensitivity and Specificity	2016
Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:1 Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Male; Maltose; Portugal; Prospective Studies; Transferrin	2017
Ferric carboxymaltose reduces the number of red blood cell units transfused and allows transfusion independence to be obtained in patients with iron deficiency anemia secondary to gastrointestinal chronic blood loss. Transfusion, 2016, Volume: 56, Issue:11 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Blood Transfusion; Female; Ferric Compounds; Gastrointestinal Hemorrhage; Humans; Male; Maltose; Middle Aged; Retrospective Studies	2016
Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry]. The American journal of cardiology, 2016, Dec-15, Volume: 118, Issue:12 Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; C-Reactive Protein; Cohort Studies; Disease Management; Female; Ferric Compounds; Germany; Heart Failure; Humans; Iron; Logistic Models; Male; Maltose; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Odds Ratio; Peptide Fragments; Prevalence; Registries; Switzerland; Trace Elements; Treatment Outcome	2016
Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron. The Journal of pediatrics, 2017, Volume: 180 Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Cohort Studies; Female; Ferric Compounds; Humans; Infant; Infusions, Intravenous; Iron; Male; Maltose; Retrospective Studies; Treatment Outcome	2017
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations. American journal of nephrology, 2017, Volume: 45, Issue:1 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Complement Activation; Complement C1q; Complement C3d; Complement Membrane Attack Complex; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Mannose-Binding Lectin; Properdin; Renal Dialysis	2017
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk. PloS one, 2016, Volume: 11, Issue:12 Topics: Administration, Intravenous; Adult; Aged; Anemia, Iron-Deficiency; Biomarkers; Disaccharides; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Phosphates; Prevalence; Retrospective Studies; Risk	2016
Definition of functional iron deficiency and intravenous iron supplementation. The Lancet. Haematology, 2016, Volume: 3, Issue:11 Topics: Anemia; Anemia, Iron-Deficiency; Dietary Supplements; Ferric Compounds; Humans; Iron; Maltose; Prospective Studies	2016
A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia. Blood transfusion = Trasfusione del sangue, 2017, Volume: 15, Issue:5 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Costs and Cost Analysis; Emergency Service, Hospital; Female; Ferric Compounds; Humans; Iron; Male; Maltose; Middle Aged	2017
Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency anemia. The Journal of pediatrics, 2017, Volume: 184 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Iron; Maltose	2017
Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients. Clinical nephrology, 2009, Volume: 71, Issue:2 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Maltose; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome	2009
Anemia and iron deficiency--new therapeutic targets in heart failure? The New England journal of medicine, 2009, Dec-17, Volume: 361, Issue:25 Topics: Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Heart Failure; Hematinics; Humans; Iron Deficiencies; Maltose; Stroke Volume	2009
Progress in intravenous iron treatment. Arzneimittel-Forschung, 2010, Volume: 60, Issue:6a Topics: Administration, Oral; Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Humans; Injections, Intramuscular; Injections, Intravenous; Iron; Iron Overload; Maltose; Recombinant Proteins; Renal Dialysis	2010
Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittel-Forschung, 2010, Volume: 60, Issue:6a Topics: Anemia; Anemia, Iron-Deficiency; Breast Feeding; Female; Ferric Compounds; Ferritins; Heart Failure; Humans; Infant; Inflammatory Bowel Diseases; Maltose; Pilot Projects; Puerperal Disorders; Randomized Controlled Trials as Topic; Renal Insufficiency; Safety; Transferrin	2010
The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Care Costs; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Young Adult	2010
Clinical perspective: iron replacement therapy in chronic heart failure. International journal of clinical practice, 2011, Volume: 65, Issue:6 Topics: Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose	2011
IBD: Intravenous iron in IBD--what's the best preparation? Nature reviews. Gastroenterology & hepatology, 2011, Jul-26, Volume: 8, Issue:9 Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Maltose; Quality of Life; Treatment Outcome	2011
IV iron in heart failure: theoretical concerns need clinical confirmation. International journal of clinical practice, 2011, Volume: 65, Issue:9 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Heart Failure; Hematinics; Humans; Maltose	2011
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Digestion, 2012, Volume: 85, Issue:1 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Cohort Studies; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Treatment Outcome; Young Adult	2012
Intravenous ferric carboxymaltose accelerates erythropoietic recovery from experimental malarial anemia. The Journal of infectious diseases, 2012, Apr-01, Volume: 205, Issue:7 Topics: Anemia, Iron-Deficiency; Animals; Disease Models, Animal; Erythropoiesis; Ferric Compounds; Growth Substances; Malaria; Male; Maltose; Mice; Mice, Inbred A; Plasmodium chabaudi; Treatment Outcome	2012
Intravenous iron among cystic fibrosis patients. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2012, Volume: 11, Issue:6 Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Infusions, Intravenous; Iron; Lung Diseases; Maltose; Retrospective Studies	2012
Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia. Journal of perinatal medicine, 2012, Apr-02, Volume: 40, Issue:4 Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Transfusion; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Maltose; Puerperal Disorders; Retrospective Studies; Treatment Outcome	2012
An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. Journal of medical economics, 2013, Volume: 16, Issue:1 Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Clinical Protocols; Costs and Cost Analysis; Decision Support Techniques; Efficiency, Organizational; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospitalization; Humans; Maltose; Patient Preference; Renal Insufficiency, Chronic; Transportation; United Kingdom	2013
Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency. PloS one, 2012, Volume: 7, Issue:9 Topics: Ambulatory Care; Anemia, Iron-Deficiency; Costs and Cost Analysis; Ferric Compounds; Humans; Infusions, Intravenous; Maltose; Monte Carlo Method; Retrospective Studies; Sucrose	2012
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:2 Topics: Aged; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Treatment Outcome	2013
Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:3 Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose	2013
Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia. The Journal of the Association of Physicians of India, 2003, Volume: 51 Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hematinics; Humans; Male; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Treatment Failure	2003